<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.jbc.org">
<title>Journal of Biological Chemistry current issue</title>
<link>http://www.jbc.org</link>
<description>Journal of Biological Chemistry RSS feed -- current issue</description>
<prism:eIssn>1083-351X</prism:eIssn>
<prism:coverDisplayDate>Jul 17 2009 12:00:00:000AM</prism:coverDisplayDate>
<prism:publicationName>Journal of Biological Chemistry</prism:publicationName>
<prism:issn>0021-9258</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19153?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19159?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19164?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19169?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19173?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19178?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19183?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19189?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19196?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19203?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19211?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19220?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19228?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19237?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19248?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19255?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19265?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19272?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19280?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19290?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19301?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19310?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19321?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19331?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19340?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19349?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19361?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19371?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19380?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19392?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19402?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19412?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19420?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19427?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19437?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19445?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19452?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19463?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19474?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19482?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19493?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19501?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19511?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19522?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19533?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19544?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19554?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19564?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19572?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19580?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19592?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19601?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19613?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19623?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19637?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19650?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19659?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19668?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19679?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19694?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19705?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19716?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19727?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19744?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/19754?rss=1" />
  <rdf:li rdf:resource="http://www.jbc.org/cgi/content/short/284/29/e99932?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://www.jbc.org/icons/banner/title.gif" />
</channel>

<image rdf:about="http://www.jbc.org/icons/banner/title.gif">
<title>Journal of Biological Chemistry</title>
<url>http://www.jbc.org/icons/banner/title.gif</url>
<link>http://www.jbc.org</link>
</image>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19153?rss=1">
<title><![CDATA[State-stabilizing Interactions in Bacterial Mechanosensitive Channel Gating and Adaptation [Minireviews]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19153?rss=1</link>
<description><![CDATA[
<p>We outline several principles that we believe define the gating of two bacterial mechanosensitive channels, MscL and MscS. Serving as turgor regulators in bacteria and other walled cells, these molecules are tangible models for studying conformational transitions in membrane proteins driven directly by membrane tension. MscL, a compact pentamer, reversibly opens a gigantic 30-&Aring; pore at near-lytic tensions. MscS, a heptameric complex, exhibits transient activation of a smaller pore at moderate tensions, thereby entering a tension-insensitive inactivated state. By comparing the structures and predicted transitions in these channels, we concluded that opening is commonly achieved through tilting and outward motion of the pore-lining helices, which is kinetically limited by hydration of the pore. The intricate adaptive behavior in MscS appears to depend on specific interhelical associations and the flexibility of the pore-lining helices. We discuss physical factors that may direct the transitions and stabilize main functional states in these channels.</p>
]]></description>
<dc:creator><![CDATA[Anishkin, A., Sukharev, S.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.R109.009357</dc:identifier>
<dc:title><![CDATA[State-stabilizing Interactions in Bacterial Mechanosensitive Channel Gating and Adaptation [Minireviews]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19157</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19153</prism:startingPage>
<prism:section>Minireviews</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19159?rss=1">
<title><![CDATA[Proinsulin and the Genetics of Diabetes Mellitus [Minireviews]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19159?rss=1</link>
<description><![CDATA[
<p>Insulin plays a central role in the regulation of vertebrate metabolism. The hormone, the post-translational product of a single-chain precursor, is a globular protein containing two chains, A (21 residues) and B (30 residues). Recent advances in human genetics have identified dominant mutations in the insulin gene causing permanent neonatal-onset DM<sup>2</sup> (<cross-ref type="bib" refid="B1">1</cross-ref><cross-ref type="bib" refid="B2"></cross-ref><cross-ref type="bib" refid="B3"></cross-ref>&ndash;<cross-ref type="bib" refid="B4">4</cross-ref>). The mutations are predicted to block folding of the precursor in the ER of pancreatic &beta;-cells. Although expression of the wild-type allele would in other circumstances be sufficient to maintain homeostasis, studies of a corresponding mouse model (<cross-ref type="bib" refid="B5">5</cross-ref><cross-ref type="bib" refid="B6"></cross-ref>&ndash;<cross-ref type="bib" refid="B7">7</cross-ref>) suggest that the misfolded variant perturbs wild-type biosynthesis (<cross-ref type="bib" refid="B8">8</cross-ref>, <cross-ref type="bib" refid="B9">9</cross-ref>). Impaired &beta;-cell secretion is associated with ER stress, distorted organelle architecture, and cell death (<cross-ref type="bib" refid="B10">10</cross-ref>). These findings have renewed interest in insulin biosynthesis (<cross-ref type="bib" refid="B11">11</cross-ref><cross-ref type="bib" refid="B12"></cross-ref>&ndash;<cross-ref type="bib" refid="B13">13</cross-ref>) and the structural basis of disulfide pairing (<cross-ref type="bib" refid="B14">14</cross-ref><cross-ref type="bib" refid="B15"></cross-ref><cross-ref type="bib" refid="B16"></cross-ref><cross-ref type="bib" refid="B17"></cross-ref><cross-ref type="bib" refid="B18"></cross-ref>&ndash;<cross-ref type="bib" refid="B19">19</cross-ref>). Protein evolution is constrained not only by structure and function but also by susceptibility to toxic misfolding.</p>
]]></description>
<dc:creator><![CDATA[Weiss, M. A.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.R109.009936</dc:identifier>
<dc:title><![CDATA[Proinsulin and the Genetics of Diabetes Mellitus [Minireviews]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19163</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19159</prism:startingPage>
<prism:section>Minireviews</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19164?rss=1">
<title><![CDATA[The Short N-terminal Domains of STIM1 and STIM2 Control the Activation Kinetics of Orai1 Channels [Accelerated Publications]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19164?rss=1</link>
<description><![CDATA[
<p>STIM1 and STIM2 are dynamic transmembrane endoplasmic reticulum Ca<sup>2+</sup> sensors, coupling directly to activate plasma membrane Orai Ca<sup>2+</sup> entry channels. Despite extensive sequence homology, the STIM proteins are functionally distinct. We reveal that the short variable N-terminal random coil sequences of STIM1 and STIM2 confer profoundly different activation properties. Using Orai1-expressing HEK293 cells, chimeric replacement of the 43-amino-acid STIM1 N terminus with that of STIM2 attenuates Orai1-mediated Ca<sup>2+</sup> entry and drastically slows store-induced Orai1 channel activation. Conversely, the 55-amino-acid STIM2 terminus substituted within STIM1 strikingly enhances both Orai1-mediated Ca<sup>2+</sup> entry and constitutive coupling to activate Orai1 channels. Hence, STIM N termini are powerful coupling modifiers, functioning in STIM2 to "brake" the otherwise constitutive activation of Orai1 channels afforded by its high sensitivity to luminal Ca<sup>2+</sup>.</p>
]]></description>
<dc:creator><![CDATA[Zhou, Y., Mancarella, S., Wang, Y., Yue, C., Ritchie, M., Gill, D. L., Soboloff, J.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.C109.010900</dc:identifier>
<dc:title><![CDATA[The Short N-terminal Domains of STIM1 and STIM2 Control the Activation Kinetics of Orai1 Channels [Accelerated Publications]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19168</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19164</prism:startingPage>
<prism:section>Accelerated Publications</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19169?rss=1">
<title><![CDATA[A Sonic Hedgehog Missense Mutation Associated with Holoprosencephaly Causes Defective Binding to GAS1 [Accelerated Publications]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19169?rss=1</link>
<description><![CDATA[
<p>Holoprosencephaly (HPE) is a common birth defect predominantly affecting the forebrain and face and has been linked to mutations in the sonic hedgehog (<I>SHH</I>) gene. HPE is genetically heterogeneous, and clinical presentation represents a spectrum of phenotypes. We have previously shown that <I>Gas1</I> encodes a cell-autonomous Hedgehog signaling enhancer. Combining cell surface binding, <I>in vitro</I> activity, and explant culture assays, we provide evidence that SHH contains a previously unknown unique binding surface for its interaction with GAS1 and that this surface is also important for maximal signaling activity. Within this surface, the Asn-115 residue of human SHH has been documented to associate with HPE when mutated to lysine (N115K). We provide evidence that HPE associated with this mutation can be mechanistically explained by a severely reduced binding of SHH to GAS1, and we predict a similar result if a mutation were to occur at Tyr-80. Our data should encourage future searches for mutations in <I>GAS1</I> as possible modifiers contributing to the wide spectrum of HPE.</p>
]]></description>
<dc:creator><![CDATA[Martinelli, D. C., Fan, C.-M.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.C109.011957</dc:identifier>
<dc:title><![CDATA[A Sonic Hedgehog Missense Mutation Associated with Holoprosencephaly Causes Defective Binding to GAS1 [Accelerated Publications]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19172</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19169</prism:startingPage>
<prism:section>Accelerated Publications</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19173?rss=1">
<title><![CDATA[Designed Human Serum Hyaluronidase 1 Variant, HYAL1{Delta}L, Exhibits Activity up to pH 5.9 [Accelerated Publications]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19173?rss=1</link>
<description><![CDATA[
<p>Hyaluronidases from diverse species and sources have different pH optima. Distinct mechanisms with regard to dynamic structural changes, which control hyaluronidase activity at varying pH, are unknown. Human serum hyaluronidase 1 (HYAL1) is active solely below pH 5.1. Here we report the design of a HYAL1 variant that degrades hyaluronan up to pH 5.9. Besides highly conserved residues in close proximity of the active site of most hyaluronidases, we identified a bulky loop formation located at the end of the substrate binding crevice of HYAL1 to be crucial for substrate hydrolysis. The stretch between cysteine residues 207 and 221, which normally contains 13 amino acids, could be replaced by a tetrapeptide sequence of alternating glycine serine residues, thereby yielding an active enzyme with an extended binding cleft. This variant exhibited hyaluronan degradation at elevated pH. This is indicative for appropriate substrate binding and proper positioning being decisively affected by sites far off from the active center.</p>
]]></description>
<dc:creator><![CDATA[Reitinger, S., Mullegger, J., Greiderer, B., Nielsen, J. E., Lepperdinger, G.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.C109.004358</dc:identifier>
<dc:title><![CDATA[Designed Human Serum Hyaluronidase 1 Variant, HYAL1{Delta}L, Exhibits Activity up to pH 5.9 [Accelerated Publications]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19177</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19173</prism:startingPage>
<prism:section>Accelerated Publications</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19178?rss=1">
<title><![CDATA[Sarcoglycan Complex: IMPLICATIONS FOR METABOLIC DEFECTS IN MUSCULAR DYSTROPHIES [Accelerated Publications]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19178?rss=1</link>
<description><![CDATA[
<p>The sarcoglycans are known as an integral subcomplex of the dystrophin glycoprotein complex, the function of which is best characterized in skeletal muscle in relation to muscular dystrophies. Here we demonstrate that the white adipocytes, which share a common precursor with the myocytes, express a cell-specific sarcoglycan complex containing &beta;-, -, and -sarcoglycan. In addition, the adipose sarcoglycan complex associates with sarcospan and laminin binding dystroglycan. Using multiple sarcoglycan null mouse models, we show that loss of -sarcoglycan has no consequence on the expression of the adipocyte sarcoglycan complex. However, loss of &beta;- or -sarcoglycan leads to a concomitant loss of the sarcoglycan complex as well as sarcospan and a dramatic reduction in dystroglycan in adipocytes. We further demonstrate that &beta;-sarcoglycan null mice, which lack the sarcoglycan complex in adipose tissue and skeletal muscle, are glucose-intolerant and exhibit whole body insulin resistance specifically due to impaired insulin-stimulated glucose uptake in skeletal muscles. Thus, our data demonstrate a novel function of the sarcoglycan complex in whole body glucose homeostasis and skeletal muscle metabolism, suggesting that the impairment of the skeletal muscle metabolism influences the pathogenesis of muscular dystrophy.</p>
]]></description>
<dc:creator><![CDATA[Groh, S., Zong, H., Goddeeris, M. M., Lebakken, C. S., Venzke, D., Pessin, J. E., Campbell, K. P.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.C109.010728</dc:identifier>
<dc:title><![CDATA[Sarcoglycan Complex: IMPLICATIONS FOR METABOLIC DEFECTS IN MUSCULAR DYSTROPHIES [Accelerated Publications]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19182</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19178</prism:startingPage>
<prism:section>Accelerated Publications</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19183?rss=1">
<title><![CDATA[The Kinase Activity of Rip2 Determines Its Stability and Consequently Nod1- and Nod2-mediated Immune Responses [Mechanisms Of Signal Transduction]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19183?rss=1</link>
<description><![CDATA[
<p>Rip2 (RICK, CARD3) has been identified as a key effector molecule downstream of the pattern recognition receptors, Nod1 and Nod2; however, its mechanism of action remains to be elucidated. In particular, it is unclear whether its kinase activity is required for signaling or for maintaining protein stability. We have investigated the expression level of different retrovirally expressed kinase-dead Rip2 mutants and the role of Rip2 kinase activity in the signaling events that follow Nod1 and Nod2 stimulation. We show that in primary cells expressing kinase-inactive Rip2, protein levels were severely compromised, and stability could not be reconstituted by the addition of a phospho-mimetic mutation in its autophosphorylation site. Consequently, inflammatory cytokine production in response to Nod1 and Nod2 ligands was abrogated both <I>in vitro</I> and <I>in vivo</I> in the absence of Rip2 kinase activity. Our results highlight the central role that Rip2 kinase activity plays in conferring stability to the protein and thus in the preservation of Nod1- and Nod2-mediated innate immune responses.</p>
]]></description>
<dc:creator><![CDATA[Nembrini, C., Kisielow, J., Shamshiev, A. T., Tortola, L., Coyle, A. J., Kopf, M., Marsland, B. J.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.006353</dc:identifier>
<dc:title><![CDATA[The Kinase Activity of Rip2 Determines Its Stability and Consequently Nod1- and Nod2-mediated Immune Responses [Mechanisms Of Signal Transduction]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19188</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19183</prism:startingPage>
<prism:section>Mechanisms Of Signal Transduction</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19189?rss=1">
<title><![CDATA[Kynurenic Acid Triggers Firm Arrest of Leukocytes to Vascular Endothelium under Flow Conditions [Molecular Basis Of Cell and Developmental Biology]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19189?rss=1</link>
<description><![CDATA[
<p>Recent studies have demonstrated that kynurenic acid (KYNA), a compound produced endogenously by the interferon--induced degradation of tryptophan by indoleamine 2,3-dioxygenase, activates the previously orphaned G protein-coupled receptor, GPR35. This receptor is expressed in immune tissues, although its potential function in immunomodulation remains to be explored. We determined that GPR35 was most highly expressed on human peripheral monocytes. In an <I>in vitro</I> vascular flow model, KYNA triggered the firm arrest of monocytes to both fibronectin and ICAM-1, via &beta;<SUB>1</SUB> integrin- and &beta;<SUB>2</SUB> integrin-mediated mechanisms, respectively. Incubation of monocytes with pertussis toxin prior to use in flow experiments significantly reduced the KYNA-induced monocyte adhesion, suggesting that adhesion is triggered by a G<SUB>i</SUB>-mediated process. Furthermore, KYNA-triggered adhesion of monocytic cells was reduced by short hairpin RNA-mediated silencing of GPR35. Although GPR35 is expressed at slightly lower levels on neutrophils, KYNA induced firm adhesion of these cells to an ICAM-1-expressing monolayer as well. KYNA also elicited neutrophil shedding of surface L-selectin, another indicator of leukocyte activation. Taken together, these data suggest that KYNA could be an important early mediator of leukocyte recruitment.</p>
]]></description>
<dc:creator><![CDATA[Barth, M. C., Ahluwalia, N., Anderson, T. J. T., Hardy, G. J., Sinha, S., Alvarez-Cardona, J. A., Pruitt, I. E., Rhee, E. P., Colvin, R. A., Gerszten, R. E.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.024042</dc:identifier>
<dc:title><![CDATA[Kynurenic Acid Triggers Firm Arrest of Leukocytes to Vascular Endothelium under Flow Conditions [Molecular Basis Of Cell and Developmental Biology]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19195</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19189</prism:startingPage>
<prism:section>Molecular Basis Of Cell and Developmental Biology</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19196?rss=1">
<title><![CDATA[A Familial Mutation Renders Atrial Natriuretic Peptide Resistant to Proteolytic Degradation [Protein Synthesis, Post-Translational Modification, and Degradation]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19196?rss=1</link>
<description><![CDATA[
<p>A heterozygous frameshift mutation causing a 12-amino acid extension to the C terminus of atrial natriuretic peptide (ANP) was recently genetically linked to patients with familial atrial fibrillation (Hodgson-Zingman, D. M., Karst, M. L., Zingman, L. V., Heublein, D. M., Darbar, D., Herron, K. J., Ballew, J. D., de Andrade, M., Burnett, J. C., Jr., and Olson, T. M. (2008) <I>N. Engl. J. Med.</I> 359, 158&ndash;165). The frameshift product (fsANP), but not wild-type ANP (wtANP), was elevated in the serum of affected patients, but the molecular basis for the elevated peptide concentrations was not determined. Here, we measured the ability of fsANP to interact with natriuretic peptide receptors and to be proteolytically degraded. fsANP and wtANP bound and activated human NPR-A and NPR-C similarly, whereas fsANP had a slightly increased efficacy for human NPR-B. Proteolytic susceptibility was addressed with novel bioassays that measure the time required for kidney membranes or purified neutral endopeptidase to abolish ANP-dependent activation of NPR-A. The half-life of fsANP was markedly greater than that of wtANP in both assays. Additional membrane proteolysis studies indicated that wtANP and fsANP are preferentially degraded by neutral endopeptidase and serine peptidases, respectively. These data indicate that the familial ANP mutation associated with atrial fibrillation has only minor effects on natriuretic peptide receptor interactions but markedly modifies peptide proteolysis.</p>
]]></description>
<dc:creator><![CDATA[Dickey, D. M., Yoder, A. R., Potter, L. R.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.010777</dc:identifier>
<dc:title><![CDATA[A Familial Mutation Renders Atrial Natriuretic Peptide Resistant to Proteolytic Degradation [Protein Synthesis, Post-Translational Modification, and Degradation]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19202</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19196</prism:startingPage>
<prism:section>Protein Synthesis, Post-Translational Modification, and Degradation</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19203?rss=1">
<title><![CDATA[Membrane Potential Greatly Enhances Superoxide Generation by the Cytochrome bc1 Complex Reconstituted into Phospholipid Vesicles [Metabolism and Bioenergetics]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19203?rss=1</link>
<description><![CDATA[
<p>The mitochondrial cytochrome <I>bc</I><SUB>1</SUB> complex (ubiquinol/cytochrome <I>c</I> oxidoreductase) is generally thought to generate superoxide anion that participates in cell signaling and contributes to cellular damage in aging and degenerative disease. However, the isolated, detergent-solubilized <I>bc</I><SUB>1</SUB> complex does not generate measurable amounts of superoxide except when inhibited by antimycin. In addition, indirect measurements of superoxide production by cells and isolated mitochondria have not clearly resolved the contribution of the <I>bc</I><SUB>1</SUB> complex to the generation of superoxide by mitochondria <I>in vivo</I>, nor did they establish the effect, if any, of membrane potential on superoxide formation by this enzyme complex. In this study we show that the yeast cytochrome <I>bc</I><SUB>1</SUB> complex does generate significant amounts of superoxide when reconstituted into phospholipid vesicles. The rate of superoxide generation by the reconstituted <I>bc</I><SUB>1</SUB> complex increased exponentially with increased magnitude of the membrane potential, a finding that is compatible with the suggestion that membrane potential inhibits electron transfer from the cytochrome <I>b</I><SUB>L</SUB> to <I>b</I><SUB>H</SUB> hemes, thereby promoting the formation of a ubisemiquinone radical that interacts with oxygen to generate superoxide. When the membrane potential was further increased, by the addition of nigericin or by the imposition of a diffusion potential, the rate of generation of superoxide was further accelerated and approached the rate obtained with antimycin. These findings suggest that the <I>bc</I><SUB>1</SUB> complex may contribute significantly to superoxide generation by mitochondria <I>in vivo</I>, and that the rate of superoxide generation can be controlled by modulation of the mitochondrial membrane potential.</p>
]]></description>
<dc:creator><![CDATA[Rottenberg, H., Covian, R., Trumpower, B. L.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.017376</dc:identifier>
<dc:title><![CDATA[Membrane Potential Greatly Enhances Superoxide Generation by the Cytochrome bc1 Complex Reconstituted into Phospholipid Vesicles [Metabolism and Bioenergetics]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19210</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19203</prism:startingPage>
<prism:section>Metabolism and Bioenergetics</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19211?rss=1">
<title><![CDATA[Activation of the Liver X Receptor Stimulates Trans-intestinal Excretion of Plasma Cholesterol [Lipids and Lipoproteins: Metabolism, Regulation, and Signaling]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19211?rss=1</link>
<description><![CDATA[
<p>Recent studies have indicated that direct intestinal secretion of plasma cholesterol significantly contributes to fecal neutral sterol loss in mice. The physiological relevance of this novel route, which represents a part of the reverse cholesterol transport pathway, has not been directly established <I>in vivo</I> as yet. We have developed a method to quantify the fractional and absolute contributions of several cholesterol fluxes to total fecal neutral sterol loss <I>in vivo</I> in mice, by assessing the kinetics of orally and intravenously administered stable isotopically labeled cholesterol combined with an isotopic approach to assess the fate of <I>de novo</I> synthesized cholesterol. Our results show that trans-intestinal cholesterol excretion significantly contributes to removal of blood-derived free cholesterol in C57Bl6/J mice (33% of 231 &micro;mol/kg/day) and that pharmacological activation of LXR with T0901317 strongly stimulates this pathway (63% of 706 &micro;mol/kg/day). Trans-intestinal cholesterol excretion is impaired in mice lacking Abcg5 (&ndash;4%), suggesting that the cholesterol transporting Abcg5/Abcg8 heterodimer is involved in this pathway. Our data demonstrate that intestinal excretion represents a quantitatively important route for fecal removal of neutral sterols independent of biliary secretion in mice. This pathway is sensitive to pharmacological activation of the LXR system. These data support the concept that the intestine substantially contributes to reverse cholesterol transport.</p>
]]></description>
<dc:creator><![CDATA[van der Veen, J. N., van Dijk, T. H., Vrins, C. L. J., van Meer, H., Havinga, R., Bijsterveld, K., Tietge, U. J. F., Groen, A. K., Kuipers, F.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.014860</dc:identifier>
<dc:title><![CDATA[Activation of the Liver X Receptor Stimulates Trans-intestinal Excretion of Plasma Cholesterol [Lipids and Lipoproteins: Metabolism, Regulation, and Signaling]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19219</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19211</prism:startingPage>
<prism:section>Lipids and Lipoproteins: Metabolism, Regulation, and Signaling</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19220?rss=1">
<title><![CDATA[Characterization of Three {beta}-Galactoside Phosphorylases from Clostridium phytofermentans: DISCOVERY OF D-GALACTOSYL-{beta}1->4-L-RHAMNOSE PHOSPHORYLASE [Enzyme Catalysis and Regulation]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19220?rss=1</link>
<description><![CDATA[
<p>We characterized three <scp>d</scp>-galactosyl-&beta;1-&gt;3-<I>N</I>-acetyl-<scp>d</scp>-hexosamine phosphorylase (EC 2.4.1.211) homologs from <I>Clostridium phytofermentans</I> (Cphy0577, Cphy1920, and Cphy3030 proteins). Cphy0577 and Cphy3030 proteins exhibited similar activity on galacto-<I>N</I>-biose (GNB; <scp>d</scp>-Gal-&beta;1-&gt;3-<scp>d</scp>-GalNAc) and lacto-<I>N</I>-biose I (LNB; <scp>d</scp>-Gal-&beta;1-&gt;3-<scp>d</scp>-GlcNAc), thus indicating that they are <scp>d</scp>-galactosyl-&beta;1-&gt;3-<I>N</I>-acetyl-<scp>d</scp>-hexosamine phosphorylases, subclassified as GNB/LNB phosphorylase. In contrast, Cphy1920 protein phosphorolyzed neither GNB nor LNB. It showed the highest activity with <scp>l</scp>-rhamnose as the acceptor in the reverse reaction using -<scp>d</scp>-galactose <scp>1</scp>-phosphate as the donor. The reaction product was <scp>d</scp>-galactosyl-&beta;1-&gt;4-<scp>l</scp>-rhamnose. The enzyme also showed activity on <scp>l</scp>-mannose, <scp>l</scp>-lyxose, <scp>d</scp>-glucose, 2-deoxy-<scp>d</scp>-glucose, and <scp>d</scp>-galactose in this order. When <scp>d</scp>-glucose derivatives were used as acceptors, reaction products were &beta;-1,3-galactosides. Kinetic parameters of phosphorolytic activity on <scp>d</scp>-galactosyl-&beta;1-&gt;4-<scp>l</scp>-rhamnose were <I>k</I><SUB>cat</SUB> = 45 s<sup>&ndash;1</sup> and <I>K<SUB>m</SUB></I> = 7.9 m<scp>m</scp>, thus indicating that these values are common among other phosphorylases. We propose <scp>d</scp>-galactosyl-&beta;1-&gt;4-<scp>l</scp>-rhamnose phosphorylase as the name for Cphy1920 protein.</p>
]]></description>
<dc:creator><![CDATA[Nakajima, M., Nishimoto, M., Kitaoka, M.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.007666</dc:identifier>
<dc:title><![CDATA[Characterization of Three {beta}-Galactoside Phosphorylases from Clostridium phytofermentans: DISCOVERY OF D-GALACTOSYL-{beta}1->4-L-RHAMNOSE PHOSPHORYLASE [Enzyme Catalysis and Regulation]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19227</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19220</prism:startingPage>
<prism:section>Enzyme Catalysis and Regulation</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19228?rss=1">
<title><![CDATA[Glucose-induced Ubiquitylation and Endocytosis of the Yeast Jen1 Transporter: ROLE OF LYSINE 63-LINKED UBIQUITIN CHAINS [Protein Synthesis, Post-Translational Modification, and Degradation]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19228?rss=1</link>
<description><![CDATA[
<p>Protein ubiquitylation is essential for many events linked to intracellular protein trafficking. Despite the significance of this process, the molecular mechanisms that govern the regulation of ubiquitylation remain largely unknown. Plasma membrane transporters are subjected to tightly regulated endocytosis, and ubiquitylation is a key signal at several stages of the endocytic pathway. The yeast monocarboxylate transporter Jen1 displays glucose-regulated endocytosis. We show here that casein kinase 1-dependent phosphorylation and HECT-ubiquitin ligase Rsp5-dependent ubiquitylation are required for Jen1 endocytosis. Ubiquitylation and endocytosis of Jen1 are induced within minutes in response to glucose addition. Jen1 is modified at the cell surface by oligo-ubiquitylation with ubiquitin-Lys<sup>63</sup> linked chain(s), and Jen1-Lys<sup>338</sup> is one of the target residues. Ubiquitin-Lys<sup>63</sup>-linked chain(s) are also required directly or indirectly to sort Jen1 into multivesicular bodies. Jen1 is one of the few examples for which ubiquitin-Lys<sup>63</sup>-linked chain(s) was shown to be required for correct trafficking at two stages of endocytosis: endocytic internalization and sorting at multivesicular bodies.</p>
]]></description>
<dc:creator><![CDATA[Paiva, S., Vieira, N., Nondier, I., Haguenauer-Tsapis, R., Casal, M., Urban-Grimal, D.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.008318</dc:identifier>
<dc:title><![CDATA[Glucose-induced Ubiquitylation and Endocytosis of the Yeast Jen1 Transporter: ROLE OF LYSINE 63-LINKED UBIQUITIN CHAINS [Protein Synthesis, Post-Translational Modification, and Degradation]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19236</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19228</prism:startingPage>
<prism:section>Protein Synthesis, Post-Translational Modification, and Degradation</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19237?rss=1">
<title><![CDATA[Neutralizing a Surface Charge on the FMN Subdomain Increases the Activity of Neuronal Nitric-oxide Synthase by Enhancing the Oxygen Reactivity of the Enzyme Heme-Nitric Oxide Complex [Enzyme Catalysis and Regulation]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19237?rss=1</link>
<description><![CDATA[
<p>Nitric-oxide synthases (NOSs) are calmodulin-dependent flavoheme enzymes that oxidize <scp>l</scp>-Arg to nitric oxide (NO) and <scp>l</scp>-citrulline. Their catalytic behaviors are complex and are determined by their rates of heme reduction (<I>k<SUB>r</SUB></I>), ferric heme-NO dissociation (<I>k<SUB>d</SUB></I>), and ferrous heme-NO oxidation (<I>k</I><SUB>ox</SUB>). We found that point mutation (E762N) of a conserved residue on the enzyme's FMN subdomain caused the NO synthesis activity to double compared with wild type nNOS. However, in the absence of <scp>l</scp>-Arg, NADPH oxidation rates suggested that electron flux through the heme was slower in E762N nNOS, and this correlated with the mutant having a 60% slower <I>k<SUB>r</SUB></I>. During NO synthesis, little heme-NO complex accumulated in the mutant, compared with ~50&ndash;70% of the wild-type nNOS accumulating as this complex. This suggested that the E762N nNOS is hyperactive because it minimizes buildup of an inactive ferrous heme-NO complex during NO synthesis. Indeed, we found that <I>k</I><SUB>ox</SUB> was 2 times faster in the E762N mutant than in wild-type nNOS. The mutational effect on <I>k</I><SUB>ox</SUB> was independent of calmodulin. Computer simulation and experimental measures both indicated that the slower <I>k<SUB>r</SUB></I> and faster <I>k</I><SUB>ox</SUB> of E762N nNOS combine to lower its apparent <I>K</I><SUB><I>m</I>,O<SUB>2</SUB></SUB> for NO synthesis by at least 5-fold, which in turn increases its <I>V/K<SUB>m</SUB></I> value and enables it to be hyperactive in steady-state NO synthesis. Our work underscores how sensitive nNOS activity is to changes in the <I>k</I><SUB>ox</SUB> and reveals a novel means for the FMN module or protein-protein interactions to alter nNOS activity.</p>
]]></description>
<dc:creator><![CDATA[Haque, M. M., Fadlalla, M., Wang, Z.-Q., Ray, S. S., Panda, K., Stuehr, D. J.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.013144</dc:identifier>
<dc:title><![CDATA[Neutralizing a Surface Charge on the FMN Subdomain Increases the Activity of Neuronal Nitric-oxide Synthase by Enhancing the Oxygen Reactivity of the Enzyme Heme-Nitric Oxide Complex [Enzyme Catalysis and Regulation]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19247</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19237</prism:startingPage>
<prism:section>Enzyme Catalysis and Regulation</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19248?rss=1">
<title><![CDATA[O-Linked N-Acetylglucosamine Modification on CCAAT Enhancer-binding Protein {beta}: ROLE DURING ADIPOCYTE DIFFERENTIATION [Protein Synthesis, Post-Translational Modification, and Degradation]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19248?rss=1</link>
<description><![CDATA[
<p>CCAAT enhancer-binding protein (C/EBP)&beta; is a basic leucine zipper transcription factor family member, and can be phosphorylated, acetylated, and sumoylated. C/EBP&beta; undergoes sequential phosphorylation during 3T3-L1 adipocyte differentiation. Phosphorylation on Thr<sup>188</sup> by MAPK or cyclin A/cdk2 primes the phosphorylations on Ser<sup>184</sup>/Thr<sup>179</sup> by GSK3&beta;, and these phosphorylations are required for the acquisition of DNA binding activity of C/EBP&beta;. Here we show that C/EBP&beta; is modified by <I>O</I>-GlcNAc, a dynamic single sugar modification found on nucleocytoplasmic proteins. The GlcNAcylation sites are Ser<sup>180</sup> and Ser<sup>181</sup>, which are in the regulation domain and are very close to the phosphorylation sites (Thr<sup>188</sup>, Ser<sup>184</sup>, and Thr<sup>179</sup>) required for the gain of DNA binding activity. Both <I>in vitro</I> and <I>ex vivo</I> experiments demonstrate that GlcNAcylation on Ser<sup>180</sup> and Ser<sup>181</sup> prevents phosphorylation on Thr<sup>188</sup>, Ser<sup>184</sup>, and Thr<sup>179</sup>, as indicated by the decreased relative phosphorylation and DNA binding activity of C/EBP&beta; delayed the adipocyte differentiation program. Mutation of both Ser<sup>180</sup> and Ser<sup>181</sup> to Ala significantly increase the transcriptional activity of C/EBP&beta;. These data suggest that GlcNAcylation regulates both the phosphorylation and DNA binding activity of C/EBP&beta;.</p>
]]></description>
<dc:creator><![CDATA[Li, X., Molina, H., Huang, H., Zhang, Y.-y., Liu, M., Qian, S.-w., Slawson, C., Dias, W. B., Pandey, A., Hart, G. W., Lane, M. D., Tang, Q.-Q.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.005678</dc:identifier>
<dc:title><![CDATA[O-Linked N-Acetylglucosamine Modification on CCAAT Enhancer-binding Protein {beta}: ROLE DURING ADIPOCYTE DIFFERENTIATION [Protein Synthesis, Post-Translational Modification, and Degradation]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19254</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19248</prism:startingPage>
<prism:section>Protein Synthesis, Post-Translational Modification, and Degradation</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19255?rss=1">
<title><![CDATA[The Pks13/FadD32 Crosstalk for the Biosynthesis of Mycolic Acids in Mycobacterium tuberculosis [Enzyme Catalysis and Regulation]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19255?rss=1</link>
<description><![CDATA[
<p>The last steps of the biosynthesis of mycolic acids, essential and specific lipids of <I>Mycobacterium tuberculosis</I> and related bacteria, are catalyzed by proteins encoded by the <I>fadD32-pks13-accD4</I> cluster. Here, we produced and purified an active form of the Pks13 polyketide synthase, with a phosphopantetheinyl (P-pant) arm at both positions Ser-55 and Ser-1266 of its two acyl carrier protein (ACP) domains. Combination of liquid chromatography-tandem mass spectrometry of protein tryptic digests and radiolabeling experiments showed that, <I>in vitro</I>, the enzyme specifically loads long-chain 2-carboxyacyl-CoA substrates onto the P-pant arm of its C-terminal ACP domain via the acyltransferase domain. The acyl-AMPs produced by the FadD32 enzyme are specifically transferred onto the ketosynthase domain after binding to the P-pant moiety of the N-terminal ACP domain of Pks13 (N-ACP<SUB>Pks13</SUB>). Unexpectedly, however, the latter step requires the presence of active FadD32. Thus, the couple FadD32-(N-ACP<SUB>Pks13</SUB>) composes the initiation module of the mycolic condensation system. Pks13 ultimately condenses the two loaded fatty acyl chains to produce -alkyl &beta;-ketoacids, the precursors of mycolic acids. The developed <I>in vitro</I> assay will constitute a strategic tool for antimycobacterial drug screening.</p>
]]></description>
<dc:creator><![CDATA[Gavalda, S., Leger, M., van der Rest, B., Stella, A., Bardou, F., Montrozier, H., Chalut, C., Burlet-Schiltz, O., Marrakchi, H., Daffe, M., Quemard, A.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.006940</dc:identifier>
<dc:title><![CDATA[The Pks13/FadD32 Crosstalk for the Biosynthesis of Mycolic Acids in Mycobacterium tuberculosis [Enzyme Catalysis and Regulation]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19264</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19255</prism:startingPage>
<prism:section>Enzyme Catalysis and Regulation</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19265?rss=1">
<title><![CDATA[Retinoblastoma/p107/p130 Pocket Proteins: PROTEIN DYNAMICS AND INTERACTIONS WITH TARGET GENE PROMOTERS [Transcription, Chromatin, and Epigenetics]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19265?rss=1</link>
<description><![CDATA[
<p>The retinoblastoma (RB) tumor suppressor and its family members, p107 and p130, function by repressing E2F transcription factor activity to limit the expression of genes required for cell cycle progression. Traditionally, it is thought that the RB family proteins repress E2F target gene expression through complexing with E2F at gene promoters. However, whereas chromatin immunoprecipitation experiments have demonstrated p107 and p130 at E2F-responsive promoters, RB chromatin association has not been reliably observed. Here we used green fluorescent protein-tagged proteins to rigorously explore the mechanism of RB-mediated transcriptional repression relative to its p107 and p130 family members. The use of live cell fluorescent imaging demonstrated that RB, p107, and p130 exhibit similar nuclear dynamics. Although these findings suggest a similar engagement with nuclear structures, chromatin immunoprecipitation approaches with multiple independent antibodies failed to detect the association of RB with target gene promoters. However, by employing antibodies directed against green fluorescent protein, we could utilize the same antibody to assess RB, p107, and p130 engagement. This approach demonstrated RB association with target gene promoters in a fashion analogous to p107 and p130. Extension of this technology demonstrated that direct RB phosphorylation disrupts promoter association to regulate transcription. Thus, RB is associated with promoters in a manner similar to p107/p130 and that association is modulated by phosphorylation during cell cycle progression.</p>
]]></description>
<dc:creator><![CDATA[Stengel, K. R., Thangavel, C., Solomon, D. A., Angus, S. P., Zheng, Y., Knudsen, E. S.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M808740200</dc:identifier>
<dc:title><![CDATA[Retinoblastoma/p107/p130 Pocket Proteins: PROTEIN DYNAMICS AND INTERACTIONS WITH TARGET GENE PROMOTERS [Transcription, Chromatin, and Epigenetics]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19271</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19265</prism:startingPage>
<prism:section>Transcription, Chromatin, and Epigenetics</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19272?rss=1">
<title><![CDATA[MicroRNA-141 and -200a Are Involved in Bone Morphogenetic Protein-2-induced Mouse Pre-osteoblast Differentiation by Targeting Distal-less Homeobox 5 [Rna-Mediated Regulation and Noncoding Rnas]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19272?rss=1</link>
<description><![CDATA[
<p>MicroRNAs (miRs) are endogenously expressed 18&ndash;25-nucleotide RNAs that regulate gene expression through translational repression by binding to a target mRNA. Recently, it was indicated that miRs act as key regulators in cell differentiation, cell growth, and cell death. In osteogenesis, several miRs (for example miR-26a, -125b, -133, and -135) regulate osteoblast cell growth or differentiation in human adipose tissue-derived stem cells, mouse mesenchymal ST2 stem cells, and mouse premyogenic C2C12 cells. Additionally, Smad proteins control Drosha-mediated miR maturation. Therefore, miRs are closely related to osteogenesis. Here we investigated miR expression profile by an miR array and identified the candidate miRs, miR-141 and -200a, as pre-osteoblast differentiation-related miRs. The effects of miR-141 and -200a on pre-osteoblast differentiation were examined by using transfection of murine pre-osteoblastic MC3T3-E1 cells with mature miR-141 or -200a and antisense inhibitor for miR-141 or -200a. It was shown that miR-141 and -200a remarkably modulated the BMP-2-induced pre-osteoblast differentiation through the translational repression of Dlx5, which is a bone-generating transcription factor expressed in pre-osteoblast differentiation. Furthermore, it was indicated that <I>Dlx5</I> is a common target of miR-141 and -200a by using a luciferase reporter assay. Thus, we have observed for the first time that miR-141 and -200a are involved in pre-osteoblast differentiation in part by regulating the expression of Dlx5.</p>
]]></description>
<dc:creator><![CDATA[Itoh, T., Nozawa, Y., Akao, Y.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.014001</dc:identifier>
<dc:title><![CDATA[MicroRNA-141 and -200a Are Involved in Bone Morphogenetic Protein-2-induced Mouse Pre-osteoblast Differentiation by Targeting Distal-less Homeobox 5 [Rna-Mediated Regulation and Noncoding Rnas]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19279</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19272</prism:startingPage>
<prism:section>Rna-Mediated Regulation and Noncoding Rnas</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19280?rss=1">
<title><![CDATA[A Regulatory Loop Composed of RAP80-HDM2-p53 Provides RAP80-enhanced p53 Degradation by HDM2 in Response to DNA Damage [Dna: Replication, Repair, Recombination, and Chromosome Dynamics]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19280?rss=1</link>
<description><![CDATA[
<p>The ubiquitin interaction motif-containing protein RAP80 plays a key role in DNA damage response signaling. Using genomic and functional analysis, we established that the expression of the <I>RAP80</I> gene is regulated in a DNA damage-responsive manner by the master regulator p53. This regulation occurs at the transcriptional level through a noncanonical p53 response element in the <I>RAP80</I> promoter. Although it is inducible by p53, RAP80 is also able to regulate p53 through an association with both p53 and the E3 ubiquitin ligase HDM2, providing HDM2-dependent enhancement of p53 polyubiquitination. Depletion of RAP80 by small interfering RNA stabilizes p53, which, following DNA damage, results in an increased transactivation of several p53 target genes as well as greater apoptosis. Consistent with these observations, exogenous expression of RAP80 selectively inhibits p53-dependent transactivation of target genes in an mdm2-dependent manner in MEF cells. Thus, we identify a new DNA damage-associated role for RAP80. It can function in an autoregulatory loop consisting of RAP80, HDM2, and the p53 master regulatory network, implying an important role for this loop in genome stability and oncogenesis.</p>
]]></description>
<dc:creator><![CDATA[Yan, J., Menendez, D., Yang, X.-P., Resnick, M. A., Jetten, A. M.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.013102</dc:identifier>
<dc:title><![CDATA[A Regulatory Loop Composed of RAP80-HDM2-p53 Provides RAP80-enhanced p53 Degradation by HDM2 in Response to DNA Damage [Dna: Replication, Repair, Recombination, and Chromosome Dynamics]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19289</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19280</prism:startingPage>
<prism:section>Dna: Replication, Repair, Recombination, and Chromosome Dynamics</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19290?rss=1">
<title><![CDATA[The Mycobacterium tuberculosis Ser/Thr Kinase Substrate Rv2175c Is a DNA-binding Protein Regulated by Phosphorylation [Protein Synthesis, Post-Translational Modification, and Degradation]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19290?rss=1</link>
<description><![CDATA[
<p>Recent efforts have underlined the role of serine/threonine protein kinases in growth, pathogenesis, and cell wall metabolism in <I>Mycobacterium tuberculosis</I>. Although most kinases have been investigated for their physiological roles, little information is available regarding how serine/threonine protein kinase-dependent phosphorylation regulates the activity of kinase substrates. Herein, we focused on <I>M. tuberculosis</I> Rv2175c, a protein of unknown function, conserved in actinomycetes, and recently identified as a substrate of the PknL kinase. We solved the solution structure of Rv2175c by multidimensional NMR and demonstrated that it possesses an original winged helix-turn-helix motif, indicative of a DNA-binding protein. The DNA-binding activity of Rv2175c was subsequently confirmed by fluorescence anisotropy, as well as in electrophoretic mobility shift assays. Mass spectrometry analyses using a combination of MALDI-TOF and LC-ESI/MS/MS identified Thr<sup>9</sup> as the unique phosphoacceptor. This was further supported by complete loss of PknL-dependent phosphorylation of an Rv2175c_T9A mutant. Importantly, the DNA-binding activity was completely abrogated in a Rv2175c_T9D mutant, designed to mimic constitutive phosphorylation, but not in a mutant lacking the first 13 residues. This implies that the function of the N-terminal extension is to provide a phosphoacceptor (Thr<sup>9</sup>), which, following phosphorylation, negatively regulates the Rv2175c DNA-binding activity. Interestingly, the N-terminal disordered extension, which bears the phosphoacceptor, was found to be restricted to members of the <I>M. tuberculosis</I> complex, thus suggesting the existence of an original mechanism that appears to be unique to the <I>M. tuberculosis</I> complex.</p>
]]></description>
<dc:creator><![CDATA[Cohen-Gonsaud, M., Barthe, P., Canova, M. J., Stagier-Simon, C., Kremer, L., Roumestand, C., Molle, V.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.019653</dc:identifier>
<dc:title><![CDATA[The Mycobacterium tuberculosis Ser/Thr Kinase Substrate Rv2175c Is a DNA-binding Protein Regulated by Phosphorylation [Protein Synthesis, Post-Translational Modification, and Degradation]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19300</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19290</prism:startingPage>
<prism:section>Protein Synthesis, Post-Translational Modification, and Degradation</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19301?rss=1">
<title><![CDATA[Arabidopsis HARMLESS TO OZONE LAYER Protein Methylates a Glucosinolate Breakdown Product and Functions in Resistance to Pseudomonas syringae pv. maculicola [Enzyme Catalysis and Regulation]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19301?rss=1</link>
<description><![CDATA[
<p>Almost all of the chlorine-containing gas emitted from natural sources is methyl chloride (CH<SUB>3</SUB>Cl), which contributes to the destruction of the stratospheric ozone layer. Tropical and subtropical plants emit substantial amounts of CH<SUB>3</SUB>Cl. A gene involved in CH<SUB>3</SUB>Cl emission from <I>Arabidopsis</I> was previously identified and designated <I>HARMLESS TO OZONE LAYER</I> (hereafter <I>AtHOL1</I>) based on the mutant phenotype. Our previous studies demonstrated that AtHOL1 and its homologs, AtHOL2 and AtHOL3, have <I>S</I>-adenosyl-<scp>l</scp>-methionine-dependent methyltransferase activities. However, the physiological functions of AtHOLs have yet to be elucidated. In the present study, our comparative kinetic analyses with possible physiological substrates indicated that all of the AtHOLs have low activities toward chloride. AtHOL1 was highly reactive to thiocyanate (NCS<sup>&ndash;</sup>), a pseudohalide, synthesizing methylthiocyanate (CH<SUB>3</SUB>SCN) with a very high <I>k</I><SUB>cat</SUB>/<I>K<SUB>m</SUB></I> value. We demonstrated <I>in vivo</I> that substantial amounts of NCS<sup>&ndash;</sup> were synthesized upon tissue damage in <I>Arabidopsis</I> and that NCS<sup>&ndash;</sup> was largely derived from myrosinase-mediated hydrolysis of glucosinolates. Analyses with the T-DNA insertion <I>Arabidopsis</I> mutants (<I>hol1</I>, <I>hol2</I>, and <I>hol3</I>) revealed that only <I>hol1</I> showed increased sensitivity to NCS<sup>&ndash;</sup> in medium and a concomitant lack of CH<SUB>3</SUB>SCN synthesis upon tissue damage. Bacterial growth assays indicated that the conversion of NCS<sup>&ndash;</sup> into CH<SUB>3</SUB>SCN dramatically increased antibacterial activities against <I>Arabidopsis</I> pathogens that normally invade the wound site. Furthermore, <I>hol1</I> seedlings showed an increased susceptibility toward an <I>Arabidopsis</I> pathogen, <I>Pseudomonas syringae</I> pv. <I>maculicola.</I> Here we propose that AtHOL1 is involved in glucosinolate metabolism and defense against phytopathogens. Moreover, CH<SUB>3</SUB>Cl synthesized by AtHOL1 could be considered a byproduct of NCS<sup>&ndash;</sup> metabolism.</p>
]]></description>
<dc:creator><![CDATA[Nagatoshi, Y., Nakamura, T.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.001032</dc:identifier>
<dc:title><![CDATA[Arabidopsis HARMLESS TO OZONE LAYER Protein Methylates a Glucosinolate Breakdown Product and Functions in Resistance to Pseudomonas syringae pv. maculicola [Enzyme Catalysis and Regulation]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19309</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19301</prism:startingPage>
<prism:section>Enzyme Catalysis and Regulation</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19310?rss=1">
<title><![CDATA[Proliferating Cell Nuclear Antigen Is Protected from Degradation by Forming a Complex with MutT Homolog2 [Protein Synthesis, Post-Translational Modification, and Degradation]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19310?rss=1</link>
<description><![CDATA[
<p>Proliferating cell nuclear antigen (PCNA) has been demonstrated to interact with multiple proteins involved in several metabolic pathways such as DNA replication and repair. However, there have been fewer reports about whether these PCNA-binding proteins influence stability of PCNA. Here, we observed a physical interaction between PCNA and MutT homolog2 (MTH2), a new member of the MutT-related proteins that hydrolyzes 8-oxo-7,8-dihydrodeoxyguanosine triphosphate (8-oxo-dGTP). In several unstressed human cancer cell lines and in normal human fibroblast cells, PCNA and MTH2 formed a complex and their mutual binding fragments were confirmed. It was intriguing that PCNA and MTH2 were dissociated dependent on acetylation of PCNA, which in turn induced degradation of PCNA in response to UV irradiation, but not in response to other forms of DNA-damaging stress. To further explore the link between dissociation of PCNA-MTH2 and degradation of PCNA, RNAi against MTH2 was performed to mimic the dissociated status of PCNA to evaluate changes in the half-life of PCNA. Knockdown of MTH2 significantly promoted degradation of PCNA, suggesting that the physiological interaction of PCNA-MTH2 may confer protection from degradation for PCNA, whereas UV irradiation accelerates PCNA degradation by inducing dissociation of PCNA-MTH2. Moreover, secondary to degradation of PCNA, UV-induced inhibition of DNA synthesis or cell cycle progression was enhanced. Collectively, our data demonstrate for the first time that PCNA is protected by this newly identified partner molecule MTH2, which is related to DNA synthesis and cell cycle progression.</p>
]]></description>
<dc:creator><![CDATA[Yu, Y., Cai, J.-P., Tu, B., Wu, L., Zhao, Y., Liu, X., Li, L., McNutt, M. A., Feng, J., He, Q., Yang, Y., Wang, H., Sekiguchi, M., Zhu, W.-G.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.015289</dc:identifier>
<dc:title><![CDATA[Proliferating Cell Nuclear Antigen Is Protected from Degradation by Forming a Complex with MutT Homolog2 [Protein Synthesis, Post-Translational Modification, and Degradation]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19320</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19310</prism:startingPage>
<prism:section>Protein Synthesis, Post-Translational Modification, and Degradation</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19321?rss=1">
<title><![CDATA[S-Adenosyl-N-decyl-aminoethyl, a Potent Bisubstrate Inhibitor of Mycobacterium tuberculosis Mycolic Acid Methyltransferases [Enzyme Catalysis and Regulation]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19321?rss=1</link>
<description><![CDATA[
<p><I>S</I>-Adenosylmethionine-dependent methyltransferases (AdoMet-MTs) constitute a large family of enzymes specifically transferring a methyl group to a range of biologically active molecules. <I>Mycobacterium tuberculosis</I> produces a set of paralogous AdoMet-MTs responsible for introducing key chemical modifications at defined positions of mycolic acids, which are essential and specific components of the mycobacterial cell envelope. We investigated the inhibition of these mycolic acid methyltransferases (MA-MTs) by structural analogs of the AdoMet cofactor. We found that <I>S</I>-adenosyl-<I>N</I>-decyl-aminoethyl, a molecule in which the amino acid moiety of AdoMet is substituted by a lipid chain, inhibited MA-MTs from <I>Mycobacterium smegmatis</I> and <I>M. tuberculosis</I> strains, both <I>in vitro</I> and <I>in vivo</I>, with IC<SUB>50</SUB> values in the submicromolar range. By contrast, <I>S</I>-adenosylhomocysteine, the demethylated reaction product, and sinefungin, a general AdoMet-MT inhibitor, did not inhibit MA-MTs. The interaction between Hma (MmaA4), which is strictly required for the biosynthesis of oxygenated mycolic acids in <I>M. tuberculosis</I>, and the three cofactor analogs was investigated by x-ray crystallography. The high resolution crystal structures obtained illustrate the bisubstrate nature of <I>S</I>-adenosyl-<I>N</I>-decyl-aminoethyl and provide insight into its mode of action in the inhibition of MA-MTs. This study has potential implications for the design of new drugs effective against multidrug-resistant and persistent tubercle bacilli.</p>
]]></description>
<dc:creator><![CDATA[Vaubourgeix, J., Bardou, F., Boissier, F., Julien, S., Constant, P., Ploux, O., Daffe, M., Quemard, A., Mourey, L.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M809599200</dc:identifier>
<dc:title><![CDATA[S-Adenosyl-N-decyl-aminoethyl, a Potent Bisubstrate Inhibitor of Mycobacterium tuberculosis Mycolic Acid Methyltransferases [Enzyme Catalysis and Regulation]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19330</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19321</prism:startingPage>
<prism:section>Enzyme Catalysis and Regulation</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19331?rss=1">
<title><![CDATA[FOXO3a Regulates Oxygen-responsive Expression of Tumor Necrosis Factor Receptor 2 in Human Dermal Microvascular Endothelial Cells [Mechanisms Of Signal Transduction]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19331?rss=1</link>
<description><![CDATA[
<p>Microvascular endothelial cell (EC) expression of tumor necrosis factor receptor (TNFR) 2 is induced <I>in situ</I> by ischemia/reperfusion injury. To assess effects of molecular oxygen on TNFR2 expression, we subjected cultured human dermal microvascular ECs (HDMECs) to hypoxic conditions (1% O<SUB>2</SUB>) or to hypoxic conditions followed by return to normoxic conditions. TNFR2 mRNA and protein are expressed under normoxic conditions but are rapidly reduced by hypoxia; they fall even further upon reoxygenation but rebound by 6&ndash;9 h. TNFR1 expression is unaffected by hypoxia or reoxygenation in these same cells. We identified a potential FOXO3a binding site in the 5' enhancer region of the <I>TNFR2</I> gene. FOXO3a from normoxic but not hypoxic HDMECs binds an oligonucleotide sequence matching this site, and the endogenous enhancer binds FOXO3a at this site in HDMECs under normoxic but not hypoxic conditions. Unphosphorylated FOXO3a is present in the nucleus of HDMECs under normoxic conditions. Hypoxia leads to FOXO3a phosphorylation at an Akt/protein kinase B target site and subsequent nuclear export; these processes are reversed by reoxygenation and blocked by LY294002, a phosphatidylinositol 3-kinase inhibitor that blocks Akt activation. LY294002 also prevents the hypoxia-mediated decrease in TNFR2 expression. Transiently transfected FOXO3a activates a TNFR2 promoter/reporter construct in HDMECs, whereas small interference RNA knockdown of FOXO3a reduces TNFR2 but not TNFR1 expression under normoxic conditions. Reduction in TNFR2 by small interference RNA sensitizes HDMECs to TNFR1-mediated apoptosis. We conclude that FOXO3a regulates oxygen-dependent changes in expression of TNFR2 in HDMECs, controlling sensitivity to TNF-mediated apoptosis.</p>
]]></description>
<dc:creator><![CDATA[Ding, B., Kirkiles-Smith, N. C., Pober, J. S.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.006536</dc:identifier>
<dc:title><![CDATA[FOXO3a Regulates Oxygen-responsive Expression of Tumor Necrosis Factor Receptor 2 in Human Dermal Microvascular Endothelial Cells [Mechanisms Of Signal Transduction]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19339</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19331</prism:startingPage>
<prism:section>Mechanisms Of Signal Transduction</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19340?rss=1">
<title><![CDATA[Identification of the C1q-binding Sites of Human C1r and C1s: A REFINED THREE-DIMENSIONAL MODEL OF THE C1 COMPLEX OF COMPLEMENT [Protein Structure and Folding]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19340?rss=1</link>
<description><![CDATA[
<p>The C1 complex of complement is assembled from a recognition protein C1q and C1s-C1r-C1r-C1s, a Ca<sup>2+</sup>-dependent tetramer of two modular proteases C1r and C1s. Resolution of the x-ray structure of the N-terminal CUB<SUB>1</SUB>-epidermal growth factor (EGF) C1s segment has led to a model of the C1q/C1s-C1r-C1r-C1s interaction where the C1q collagen stem binds at the C1r/C1s interface through ionic bonds involving acidic residues contributed by the C1r EGF module (Gregory, L. A., Thielens, N. M., Arlaud, G. J., Fontecilla-Camps, J. C., and Gaboriaud, C. (2003) <I>J. Biol. Chem.</I> 278, 32157&ndash;32164). To identify the C1q-binding sites of C1s-C1r-C1r-C1s, a series of C1r and C1s mutants was expressed, and the C1q binding ability of the resulting tetramer variants was assessed by surface plasmon resonance. Mutations targeting the Glu<sup>137</sup>-Glu-Asp<sup>139</sup> stretch in the C1r EGF module had no effect on C1 assembly, ruling out our previous interaction model. Additional mutations targeting residues expected to participate in the Ca<sup>2+</sup>-binding sites of the C1r and C1s CUB modules provided evidence for high affinity C1q-binding sites contributed by the C1r CUB<SUB>1</SUB> and CUB<SUB>2</SUB> modules and lower affinity sites contributed by C1s CUB<SUB>1</SUB>. All of the sites implicate acidic residues also contributing Ca<sup>2+</sup> ligands. C1s-C1r-C1r-C1s thus contributes six C1q-binding sites, one per C1q stem. Based on the location of these sites and available structural information, we propose a refined model of C1 assembly where the CUB<SUB>1</SUB>-EGF-CUB<SUB>2</SUB> interaction domains of C1r and C1s are entirely clustered inside C1q and interact through six binding sites with reactive lysines of the C1q stems. This mechanism is similar to that demonstrated for mannan-binding lectin (MBL)-MBL-associated serine protease and ficolin-MBL-associated serine protease complexes.</p>
]]></description>
<dc:creator><![CDATA[Bally, I., Rossi, V., Lunardi, T., Thielens, N. M., Gaboriaud, C., Arlaud, G. J.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.004473</dc:identifier>
<dc:title><![CDATA[Identification of the C1q-binding Sites of Human C1r and C1s: A REFINED THREE-DIMENSIONAL MODEL OF THE C1 COMPLEX OF COMPLEMENT [Protein Structure and Folding]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19348</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19340</prism:startingPage>
<prism:section>Protein Structure and Folding</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19349?rss=1">
<title><![CDATA[14-3-3 Protein Masks the DNA Binding Interface of Forkhead Transcription Factor FOXO4 [Protein Structure and Folding]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19349?rss=1</link>
<description><![CDATA[
<p>The role of 14-3-3 proteins in the regulation of FOXO forkhead transcription factors is at least 2-fold. First, the 14-3-3 binding inhibits the interaction between the FOXO and the target DNA. Second, the 14-3-3 proteins prevent nuclear reimport of FOXO factors by masking their nuclear localization signal. The exact mechanisms of these processes are still unclear, mainly due to the lack of structural data. In this work, we used fluorescence spectroscopy to investigate the mechanism of the 14-3-3 protein-dependent inhibition of FOXO4 DNA-binding properties. Time-resolved fluorescence measurements revealed that the 14-3-3 binding affects fluorescence properties of 5-(((acetylamino)ethyl)amino) naphthalene-1-sulfonic acid moiety attached at four sites within the forkhead domain of FOXO4 that represent important parts of the DNA binding interface. Observed changes in 5-(((acetylamino)ethyl)amino) naphthalene-1-sulfonic acid fluorescence strongly suggest physical contacts between the 14-3-3 protein and labeled parts of the FOXO4 DNA binding interface. The 14-3-3 protein binding, however, does not cause any dramatic conformational change of FOXO4 as documented by the results of tryptophan fluorescence experiments. To build a realistic model of the FOXO4&middot;14-3-3 complex, we measured six distances between 14-3-3 and FOXO4 using F&ouml;rster resonance energy transfer time-resolved fluorescence experiments. The model of the complex suggests that the forkhead domain of FOXO4 is docked within the central channel of the 14-3-3 protein dimer, consistent with our hypothesis that 14-3-3 masks the DNA binding interface of FOXO4.</p>
]]></description>
<dc:creator><![CDATA[Silhan, J., Vacha, P., Strnadova, P., Vecer, J., Herman, P., Sulc, M., Teisinger, J., Obsilova, V., Obsil, T.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.002725</dc:identifier>
<dc:title><![CDATA[14-3-3 Protein Masks the DNA Binding Interface of Forkhead Transcription Factor FOXO4 [Protein Structure and Folding]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19360</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19349</prism:startingPage>
<prism:section>Protein Structure and Folding</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19361?rss=1">
<title><![CDATA[Ubiquitination Regulates Proteolytic Processing of G Protein-coupled Receptors after Their Sorting to Lysosomes [Mechanisms Of Signal Transduction]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19361?rss=1</link>
<description><![CDATA[
<p>Ubiquitination is essential for the endocytic sorting of various G protein-coupled receptors to lysosomes. Here we identify a distinct function of this covalent modification in controlling the later proteolytic processing of receptors. Mutation of all cytoplasmic lysine residues in the murine -opioid receptor blocked receptor ubiquitination without preventing ligand-induced endocytosis of receptors or their subsequent delivery to lysosomes, as verified by proteolysis of extramembrane epitope tags and down-regulation of radioligand binding to the transmembrane helices. Surprisingly, a functional screen revealed that the E3 ubiquitin ligase AIP4 specifically controls down-regulation of wild type receptors measured by radioligand binding without detectably affecting receptor delivery to lysosomes defined both immunochemically and biochemically. This specific AIP4-dependent regulation required direct ubiquitination of receptors and was also regulated by two deubiquitinating enzymes, AMSH and UBPY, which localized to late endosome/lysosome membranes containing internalized -opioid receptor. These results identify a distinct function of AIP4-dependent ubiquitination in controlling the later proteolytic processing of G protein-coupled receptors, without detectably affecting their endocytic sorting to lysosomes. We propose that ubiquitination or ubiquitination/deubiquitination cycling specifically regulates later proteolytic processing events required for destruction of the receptor's hydrophobic core.</p>
]]></description>
<dc:creator><![CDATA[Hislop, J. N., Henry, A. G., Marchese, A., von Zastrow, M.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.001644</dc:identifier>
<dc:title><![CDATA[Ubiquitination Regulates Proteolytic Processing of G Protein-coupled Receptors after Their Sorting to Lysosomes [Mechanisms Of Signal Transduction]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19370</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19361</prism:startingPage>
<prism:section>Mechanisms Of Signal Transduction</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19371?rss=1">
<title><![CDATA[Crystal Structure of a Class XIB Phospholipase A2 (PLA2): RICE (ORYZA SATIVA) ISOFORM-2 PLA2 AND AN OCTANOATE COMPLEX [Protein Structure and Folding]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19371?rss=1</link>
<description><![CDATA[
<p>Phospholipase A<SUB>2</SUB> catalyzes the specific hydrolysis of the <I>sn</I>-2 acyl bond of various glycerophospholipids, producing fatty acids and lysophospholipids. Phospholipase A<SUB>2</SUB>s (PLA<SUB>2</SUB>s) constitute a large superfamily of enzymes whose products are important for a multitude of signal transduction processes, lipid mediator release, lipid metabolism, development, plant stress responses, and host defense. The crystal structure of rice (<I>Oryza sativa</I>) isoform 2 phospholipase A<SUB>2</SUB> has been determined to 2.0 &Aring; resolution using sulfur SAD phasing, and shows that the class XIb phospholipases have a unique structure compared with other secreted PLA<SUB>2</SUB>s. The N-terminal half of the chain contains mainly loop structure, including the conserved Ca<sup>2+</sup>-binding loop, but starts with a short 3<SUB>10</SUB>-helix and also includes two short anti-parallel &beta;-strands. The C-terminal half is folded into three anti-parallel -helices, of which the two first are also present in other secreted PLA<SUB>2</SUB>s and contain the conserved catalytic histidine and calcium liganding aspartate residues. The structure is stabilized by six disulfide bonds. The water structure around the calcium ion binding site suggests the involvement of a second water molecule in the mechanism for hydrolysis, the water-assisted calcium-coordinate oxyanion mechanism. The octanoate molecule in the complex structure is bound in a hydrophobic pocket, which extends to the likely membrane interface and is proposed to model the binding of the product fatty acid. Due to the differences in structure, the suggested surface for binding to the membrane has a different morphology in the rice PLA<SUB>2</SUB> compared with other phospholipases.</p>
]]></description>
<dc:creator><![CDATA[Guy, J. E., Stahl, U., Lindqvist, Y.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.008466</dc:identifier>
<dc:title><![CDATA[Crystal Structure of a Class XIB Phospholipase A2 (PLA2): RICE (ORYZA SATIVA) ISOFORM-2 PLA2 AND AN OCTANOATE COMPLEX [Protein Structure and Folding]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19379</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19371</prism:startingPage>
<prism:section>Protein Structure and Folding</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19380?rss=1">
<title><![CDATA[Repeated Domains of Leptospira Immunoglobulin-like Proteins Interact with Elastin and Tropoelastin [Protein Structure and Folding]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19380?rss=1</link>
<description><![CDATA[
<p><I>Leptospira</I> spp., the causative agents of leptospirosis, adhere to components of the extracellular matrix, a pivotal role for colonization of host tissues during infection. Previously, we and others have shown that <I>Leptospira</I> immunoglobulin-like proteins (Lig) of <I>Leptospira</I> spp. bind to fibronectin, laminin, collagen, and fibrinogen. In this study, we report that <I>Leptospira</I> can be immobilized by human tropoelastin (HTE) or elastin from different tissues, including lung, skin, and blood vessels, and that Lig proteins can bind to HTE or elastin. Moreover, both elastin and HTE bind to the same LigB immunoglobulin-like domains, including LigBCon4, LigBCen7'&ndash;8, LigBCen9, and LigBCen12 as demonstrated by enzyme-linked immunosorbent assay (ELISA) and competition ELISAs. The LigB immunoglobulin-like domain binds to the 17th to 27th exons of HTE (17&ndash;27HTE) as determined by ELISA (LigBCon4, <I>K<SUB>D</SUB></I> = 0.50 &micro;<scp>m;</scp> LigBCen7'&ndash;8, <I>K<SUB>D</SUB></I> = 0.82 &micro;<scp>m</scp>; LigBCen9, <I>K<SUB>D</SUB></I> = 1.54 &micro;<scp>m</scp>; and LigBCen12, <I>K<SUB>D</SUB></I> = 0.73 &micro;<scp>m</scp>). The interaction of LigBCon4 and 17&ndash;27HTE was further confirmed by steady state fluorescence spectroscopy (<I>K<SUB>D</SUB></I> = 0.49 &micro;<scp>m</scp>) and ITC (<I>K<SUB>D</SUB></I> = 0.54 &micro;<scp>m</scp>). Furthermore, the binding was enthalpy-driven and affected by environmental pH, indicating it is a charge-charge interaction. The binding affinity of LigBCon4D341N to 17&ndash;27HTE was 4.6-fold less than that of wild type LigBCon4. In summary, we show that Lig proteins of <I>Leptospira</I> spp. interact with elastin and HTE, and we conclude this interaction may contribute to <I>Leptospira</I> adhesion to host tissues during infection.</p>
]]></description>
<dc:creator><![CDATA[Lin, Y.-P., Lee, D.-W., McDonough, S. P., Nicholson, L. K., Sharma, Y., Chang, Y.-F.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.004531</dc:identifier>
<dc:title><![CDATA[Repeated Domains of Leptospira Immunoglobulin-like Proteins Interact with Elastin and Tropoelastin [Protein Structure and Folding]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19391</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19380</prism:startingPage>
<prism:section>Protein Structure and Folding</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19392?rss=1">
<title><![CDATA[Docking of PRAK/MK5 to the Atypical MAPKs ERK3 and ERK4 Defines a Novel MAPK Interaction Motif [Mechanisms Of Signal Transduction]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19392?rss=1</link>
<description><![CDATA[
<p>ERK3 and ERK4 are atypical MAPKs in which the canonical T<I>X</I>Y motif within the activation loop of the classical MAPKs is replaced by SEG. Both ERK3 and ERK4 bind, translocate, and activate the MAPK-activated protein kinase (MK) 5. The classical MAPKs ERK1/2 and p38 interact with downstream MKs (RSK1&ndash;3 and MK2&ndash;3, respectively) through conserved clusters of acidic amino acids, which constitute the common docking (CD) domain. In contrast to the classical MAPKs, the interaction between ERK3/4 and MK5 is strictly dependent on phosphorylation of the SEG motif of these kinases. Here we report that the conserved CD domain is dispensable for the interaction of ERK3 and ERK4 with MK5. Using peptide overlay assays, we have defined a novel MK5 interaction motif (FRIEDE) within both ERK4 and ERK3 that is essential for binding to the C-terminal region of MK5. This motif is located within the L16 extension lying C-terminal to the CD domain in ERK3 and ERK4 and a single isoleucine to lysine substitution in FRIEDE totally abrogates binding, activation, and translocation of MK5 by both ERK3 and ERK4. These findings are the first to demonstrate binding of a physiological substrate via this region of the L16 loop in a MAPK. Furthermore, the link between activation loop phosphorylation and accessibility of the FRIEDE interaction motif suggests a switch mechanism for these atypical MAPKs in which the phosphorylation status of the activation loop regulates the ability of both ERK3 and ERK4 to bind to a downstream effector.</p>
]]></description>
<dc:creator><![CDATA[Aberg, E., Torgersen, K. M., Johansen, B., Keyse, S. M., Perander, M., Seternes, O.-M.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.023283</dc:identifier>
<dc:title><![CDATA[Docking of PRAK/MK5 to the Atypical MAPKs ERK3 and ERK4 Defines a Novel MAPK Interaction Motif [Mechanisms Of Signal Transduction]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19401</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19392</prism:startingPage>
<prism:section>Mechanisms Of Signal Transduction</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19402?rss=1">
<title><![CDATA[Structural Determinants of G-protein {alpha} Subunit Selectivity by Regulator of G-protein Signaling 2 (RGS2) [Mechanisms Of Signal Transduction]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19402?rss=1</link>
<description><![CDATA[
<p>"Regulator of G-protein signaling" (RGS) proteins facilitate the termination of G protein-coupled receptor (GPCR) signaling via their ability to increase the intrinsic GTP hydrolysis rate of G subunits (known as GTPase-accelerating protein or "GAP" activity). RGS2 is unique in its <I>in vitro</I> potency and selectivity as a GAP for G<SUB>q</SUB> subunits. As many vasoconstrictive hormones signal via G<SUB>q</SUB> heterotrimer-coupled receptors, it is perhaps not surprising that RGS2-deficient mice exhibit constitutive hypertension. However, to date the particular structural features within RGS2 determining its selectivity for G<SUB>q</SUB> over G<SUB>i/o</SUB> substrates have not been completely characterized. Here, we examine a trio of point mutations to RGS2 that elicits G<SUB>i</SUB>-directed binding and GAP activities without perturbing its association with G<SUB>q</SUB>. Using x-ray crystallography, we determined a model of the triple mutant RGS2 in complex with a transition state mimetic form of G<SUB>i</SUB> at 2.8-&Aring; resolution. Structural comparison with unliganded, wild type RGS2 and of other RGS domain/G complexes highlighted the roles of these residues in wild type RGS2 that weaken G<SUB>i</SUB> subunit association. Moreover, these three amino acids are seen to be evolutionarily conserved among organisms with modern cardiovascular systems, suggesting that RGS2 arose from the R4-subfamily of RGS proteins to have specialized activity as a potent and selective G<SUB>q</SUB> GAP that modulates cardiovascular function.</p>
]]></description>
<dc:creator><![CDATA[Kimple, A. J., Soundararajan, M., Hutsell, S. Q., Roos, A. K., Urban, D. J., Setola, V., Temple, B. R. S., Roth, B. L., Knapp, S., Willard, F. S., Siderovski, D. P.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.024711</dc:identifier>
<dc:title><![CDATA[Structural Determinants of G-protein {alpha} Subunit Selectivity by Regulator of G-protein Signaling 2 (RGS2) [Mechanisms Of Signal Transduction]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19411</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19402</prism:startingPage>
<prism:section>Mechanisms Of Signal Transduction</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19412?rss=1">
<title><![CDATA[Structure and Biochemical Characterization of Protein Acetyltransferase from Sulfolobus solfataricus [Transcription, Chromatin, and Epigenetics]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19412?rss=1</link>
<description><![CDATA[
<p>The <I>Sulfolobus solfataricus</I> protein acetyltransferase (PAT) acetylates ALBA, an abundant nonspecific DNA-binding protein, on Lys<sup>16</sup> to reduce its DNA affinity, and the Sir2 deacetylase reverses the modification to cause transcriptional repression. This represents a "primitive" model for chromatin regulation analogous to histone modification in eukaryotes. We report the 1.84-&Aring; crystal structure of PAT in complex with coenzyme A. The structure reveals homology to both prokaryotic GNAT acetyltransferases and eukaryotic histone acetyltransferases (HATs), with an additional "bent helix" proximal to the substrate binding site that might play an autoregulatory function. Investigation of active site mutants suggests that PAT does not use a single general base or acid residue for substrate deprotonation and product reprotonation, respectively, and that a diffusional step, such as substrate binding, may be rate-limiting. The catalytic efficiency of PAT toward ALBA is low relative to other acetyltransferases, suggesting that there may be better, unidentified substrates for PAT. The structural similarity of PAT to eukaryotic HATs combined with its conserved role in chromatin regulation suggests that PAT is evolutionarily related to the eukaryotic HATs.</p>
]]></description>
<dc:creator><![CDATA[Brent, M. M., Iwata, A., Carten, J., Zhao, K., Marmorstein, R.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.014951</dc:identifier>
<dc:title><![CDATA[Structure and Biochemical Characterization of Protein Acetyltransferase from Sulfolobus solfataricus [Transcription, Chromatin, and Epigenetics]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19419</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19412</prism:startingPage>
<prism:section>Transcription, Chromatin, and Epigenetics</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19420?rss=1">
<title><![CDATA[Interleukin-33 Is Biologically Active Independently of Caspase-1 Cleavage [Protein Synthesis, Post-Translational Modification, and Degradation]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19420?rss=1</link>
<description><![CDATA[
<p>The new interleukin (IL)-1 family cytokine IL-33 is synthesized as a 30-kDa precursor. Like pro-IL-1&beta;, human pro-IL-33 was reported to be cleaved by caspase-1 to generate an 18-kDa fragment, which is sufficient to activate signaling by the IL-33 receptor T1/ST2. However, the proposed caspase-1 cleavage site is poorly conserved between species. In addition, it is not clear whether caspase-1 cleavage of pro-IL-33 occurs <I>in vivo</I> and whether, as for IL-1&beta;, this cleavage is a prerequisite for IL-33 secretion and bioactivity. In this study, we further investigated caspase-1 cleavage of mouse and human pro-IL-33 and assessed the potential bioactivity of the IL-33 precursor. We observed the generation of a 20-kDa IL-33 fragment in cell lysates, which was enhanced by incubation with caspase-1. However, <I>in vitro</I> assays of mouse and human pro-IL-33 indicated that IL-33 is not a direct substrate for this enzyme. Consistently, caspase-1 activation in THP-1 cells induced cleavage of pro-IL-1&beta; but not of pro-IL-33, and activated THP-1 cells released full-length pro-IL-33 into culture supernatants. Finally, addition of full-length pro-IL-33 induced T1/ST2-dependent IL-6 secretion in mast cells. However, we observed <I>in situ</I> processing of pro-IL-33 in mast cell cultures, and it remains to be determined whether full-length pro-IL-33 itself indeed represents the bioactive species. In conclusion, our data indicate that pro-IL-33 is not a direct substrate for caspase-1. In addition, our results clearly show that caspase-1 cleavage is not required for pro-IL-33 secretion and bioactivity, highlighting major differences between IL-1&beta; and IL-33.</p>
]]></description>
<dc:creator><![CDATA[Talabot-Ayer, D., Lamacchia, C., Gabay, C., Palmer, G.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M901744200</dc:identifier>
<dc:title><![CDATA[Interleukin-33 Is Biologically Active Independently of Caspase-1 Cleavage [Protein Synthesis, Post-Translational Modification, and Degradation]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19426</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19420</prism:startingPage>
<prism:section>Protein Synthesis, Post-Translational Modification, and Degradation</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19427?rss=1">
<title><![CDATA[Cdc42 and the Phosphatidylinositol 3-Kinase-Akt Pathway Are Essential for PspC-mediated Internalization of Pneumococci by Respiratory Epithelial Cells [Mechanisms Of Signal Transduction]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19427?rss=1</link>
<description><![CDATA[
<p>The pneumococcal surface protein C (PspC) is a major adhesin of <I>Streptococcus pneumoniae</I>, the cause of lobar pneumonia and invasive diseases. PspC interacts in a human-specific manner with the ectodomain of the human polymeric immunoglobulin receptor (pIgR) produced by respiratory epithelial cells. By adopting the retrograde machinery of human pIgR, this protein-protein interaction promotes colonization and transcytosis across the epithelial layer. Here, we explored the role of Rho family guanosine triphosphatases (GTPases), phosphatidylinositol 3-kinase (PI3K) and protein kinase B (Akt) for ingestion of pneumococci via the human pIgR. Inhibition experiments suggested that the host-cell actin microfilaments and microtubules are essential for this pneumococcal uptake mechanism. By using specific GTPase-modifying toxins, inhibitors, and GTPase expression constructs we demonstrate that Cdc42, but not Rac1 and RhoA are involved in PspC-mediated invasion of pneumococci into host cells. Accordingly, Cdc42 is time-dependently activated during ingestion of pneumococci. In addition, PI3K and Akt are essential for ingestion of pneumococci by respiratory epithelial cells via the PspC-pIgR interaction. The subunit p85 of PI3K and Akt was activated during the infection process. Moreover, Akt activation upon pneumococcal invasion depends on PI3K. In conclusion, our results illustrate for the first time key signaling molecules of host cells that are required for PspC-pIgR-mediated invasion of pneumococci into epithelial cells. This unique and specific bacterial entry process is dependent on the cooperation and activation of Rho family GTPase Cdc42, PI3K, and Akt.</p>
]]></description>
<dc:creator><![CDATA[Agarwal, V., Hammerschmidt, S.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.003442</dc:identifier>
<dc:title><![CDATA[Cdc42 and the Phosphatidylinositol 3-Kinase-Akt Pathway Are Essential for PspC-mediated Internalization of Pneumococci by Respiratory Epithelial Cells [Mechanisms Of Signal Transduction]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19436</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19427</prism:startingPage>
<prism:section>Mechanisms Of Signal Transduction</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19437?rss=1">
<title><![CDATA[Phospholipase C-{gamma} Binds Directly to the Na+/H+ Exchanger 3 and Is Required for Calcium Regulation of Exchange Activity [Mechanisms Of Signal Transduction]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19437?rss=1</link>
<description><![CDATA[
<p>Multiple studies suggest that phospholipase C- (PLC-) contributes to regulation of sodium/hydrogen exchanger 3 (NHE3) in the small intestine, although the mechanism(s) for this regulation remain unknown. We demonstrate here that PLC- binds directly to the C terminus of NHE3 and exists in similar sized multiprotein complexes as NHE3. This binding is dynamic and decreases with elevated [Ca<sup>2+</sup>]<I><SUB>i</SUB></I>. The PLC--binding site in NHE3 was identified (amino acids 586&ndash;605) and shown to be a critical regulatory domain for protein complex formation, because when it is mutated, NHE3 binding to PLC- as well as NHERF2 is lost. An inhibitory peptide, which binds to the Src homology 2 domains contained in PLC- without interrupting binding of PLC- to NHE3, was used to probe a non-lipase-dependent role of PLC-. In the presence of this peptide, carbachol-stimulated calcium inhibition of NHE3 was lost. These results mirror previous studies with the transient receptor potential channel and suggest that PLC- may play a common role in regulating the cell-surface expression of ion transporters.</p>
]]></description>
<dc:creator><![CDATA[Zachos, N. C., van Rossum, D. B., Li, X., Caraveo, G., Sarker, R., Cha, B., Mohan, S., Desiderio, S., Patterson, R. L., Donowitz, M.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.006098</dc:identifier>
<dc:title><![CDATA[Phospholipase C-{gamma} Binds Directly to the Na+/H+ Exchanger 3 and Is Required for Calcium Regulation of Exchange Activity [Mechanisms Of Signal Transduction]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19444</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19437</prism:startingPage>
<prism:section>Mechanisms Of Signal Transduction</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19445?rss=1">
<title><![CDATA[Synaptotagmin-2 Controls Regulated Exocytosis but Not Other Secretory Responses of Mast Cells [Membrane Transport, Structure, Function, and Biogenesis]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19445?rss=1</link>
<description><![CDATA[
<p>Mast cell degranulation is a highly regulated, calcium-dependent process, which is important for the acute release of inflammatory mediators during the course of many pathological conditions. We previously found that Synaptotagmin-2, a calcium sensor in neuronal exocytosis, was expressed in a mast cell line. We postulated that this protein may be involved in the control of mast cell-regulated exocytosis, and we generated Synaptotagmin-2 knock-out mice to test our hypothesis. Mast cells from this mutant animal conferred an abnormally decreased passive cutaneous anaphylaxis reaction on mast cell-deficient mice that correlated with a specific defect in mast cell-regulated exocytosis, leaving constitutive exocytosis and nonexocytic mast cell effector responses intact. This defect was not secondary to abnormalities in the development, maturation, migration, morphology, synthesis, and storage of inflammatory mediators, or intracellular calcium transients of the mast cells. Unlike neurons, the lack of Synaptotagmin-2 in mast cells was not associated with increased spontaneous exocytosis.</p>
]]></description>
<dc:creator><![CDATA[Melicoff, E., Sansores-Garcia, L., Gomez, A., Moreira, D. C., Datta, P., Thakur, P., Petrova, Y., Siddiqi, T., Murthy, J. N., Dickey, B. F., Heidelberger, R., Adachi, R.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.002550</dc:identifier>
<dc:title><![CDATA[Synaptotagmin-2 Controls Regulated Exocytosis but Not Other Secretory Responses of Mast Cells [Membrane Transport, Structure, Function, and Biogenesis]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19451</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19445</prism:startingPage>
<prism:section>Membrane Transport, Structure, Function, and Biogenesis</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19452?rss=1">
<title><![CDATA[Differential Regulation of Transforming Growth Factor {beta} Signaling Pathways by Notch in Human Endothelial Cells [Molecular Basis Of Cell and Developmental Biology]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19452?rss=1</link>
<description><![CDATA[
<p>Notch and transforming growth factor &beta; (TGF&beta;) play critical roles in endothelial-to-mesenchymal transition (EndMT), a process that is essential for heart development. Previously, we have shown that Notch and TGF&beta; signaling synergistically induce Snail expression in endothelial cells, which is required for EndMT in cardiac cushion morphogenesis. Here, we report that Notch activation modulates TGF&beta; signaling pathways in a receptor-activated Smad (R-Smad)-specific manner. Notch activation inhibits TGF&beta;/Smad1 and TGF&beta;/Smad2 signaling pathways by decreasing the expression of Smad1 and Smad2 and their target genes. In contrast, Notch increases <I>SMAD3</I> mRNA expression and protein half-life and regulates the expression of TGF&beta;/Smad3 target genes in a gene-specific manner. Inhibition of Notch in the cardiac cushion of mouse embryonic hearts reduces Smad3 expression. Notch and TGF&beta; synergistically up-regulate a subset of genes by recruiting Smad3 to both Smad and CSL binding sites and cooperatively inducing histone H4 acetylation. This is the first evidence that Notch activation affects R-Smad expression and that cooperative induction of histone acetylation at specific promoters underlies the selective synergy between Notch and TGF&beta; signaling pathways.</p>
]]></description>
<dc:creator><![CDATA[Fu, Y., Chang, A., Chang, L., Niessen, K., Eapen, S., Setiadi, A., Karsan, A.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.011833</dc:identifier>
<dc:title><![CDATA[Differential Regulation of Transforming Growth Factor {beta} Signaling Pathways by Notch in Human Endothelial Cells [Molecular Basis Of Cell and Developmental Biology]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19462</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19452</prism:startingPage>
<prism:section>Molecular Basis Of Cell and Developmental Biology</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19463?rss=1">
<title><![CDATA[A Genome-wide Short Hairpin RNA Screening of Jurkat T-cells for Human Proteins Contributing to Productive HIV-1 Replication [Genomics, Proteomics, and Bioinformatics]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19463?rss=1</link>
<description><![CDATA[
<p>Short interfering RNAs (siRNAs) have been used to inhibit HIV-1 replication. The durable inhibition of HIV-1 replication by RNA interference has been impeded, however, by a high mutation rate when viral sequences are targeted and by cytotoxicity when cellular genes are knocked down. To identify cellular proteins that contribute to HIV-1 replication that can be chronically silenced without significant cytotoxicity, we employed a shRNA library that targets 54,509 human transcripts. We used this library to select a comprehensive population of Jurkat T-cell clones, each expressing a single discrete shRNA. The Jurkat clones were then infected with HIV-1. Clones that survived viral infection represent moieties silenced for a human mRNA needed for virus replication, but whose chronic knockdown did not cause cytotoxicity. Overall, 252 individual Jurkat mRNAs were identified. Twenty-two of these mRNAs were secondarily verified for their contributions to HIV-1 replication. Five mRNAs, <I>NRF1</I>, <I>STXBP2</I>, <I>NCOA3</I>, <I>PRDM2</I>, and <I>EXOSC5</I>, were studied for their effect on steps of the HIV-1 life cycle. We discuss the similarities and differences between our shRNA findings for HIV-1 using a spreading infection assay in human Jurkat T-cells and results from other investigators who used siRNA-based screenings in HeLa or 293T cells.</p>
]]></description>
<dc:creator><![CDATA[Yeung, M. L., Houzet, L., Yedavalli, V. S. R. K., Jeang, K.-T.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.010033</dc:identifier>
<dc:title><![CDATA[A Genome-wide Short Hairpin RNA Screening of Jurkat T-cells for Human Proteins Contributing to Productive HIV-1 Replication [Genomics, Proteomics, and Bioinformatics]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19473</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19463</prism:startingPage>
<prism:section>Genomics, Proteomics, and Bioinformatics</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19474?rss=1">
<title><![CDATA[Proteolytic Cascade for the Activation of the Insect Toll Pathway Induced by the Fungal Cell Wall Component [Enzyme Catalysis and Regulation]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19474?rss=1</link>
<description><![CDATA[
<p>The insect Toll signaling pathway is activated upon recognition of Gram-positive bacteria and fungi, resulting in the expression of antimicrobial peptides via NF-B-like transcription factor. This activation is mediated by a serine protease cascade leading to the processing of Sp&auml;tzle, which generates the functional ligand of the Toll receptor. Recently, we identified three serine proteases mediating Toll pathway activation induced by lysine-type peptidoglycan of Gram-positive bacteria. However, the identities of the downstream serine protease components of Gram-negative-binding protein 3 (GNBP3), a receptor for a major cell wall component &beta;-1,3-glucan of fungi, and their order of activation have not been characterized yet. Here, we identified three serine proteases that are required for Toll activation by &beta;-1,3-glucan in the larvae of a large beetle, <I>Tenebrio molitor</I>. The first one is a modular serine protease functioning immediately downstream of GNBP3 that proteolytically activates the second one, a Sp&auml;tzle-processing enzyme-activating enzyme that in turn activates the third serine protease, a Sp&auml;tzle-processing enzyme. The active form of Sp&auml;tzle-processing enzyme then cleaves Sp&auml;tzle into the processed Sp&auml;tzle as Toll ligand. In addition, we show that injection of &beta;-1,3-glucan into <I>Tenebrio</I> larvae induces production of two antimicrobial peptides, Tenecin 1 and Tenecin 2, which are also inducible by injection of the active form of Sp&auml;tzle-processing enzyme-activating enzyme or processed Sp&auml;tzle. These results demonstrate a three-step proteolytic cascade essential for the Toll pathway activation by fungal &beta;-1,3-glucan in <I>Tenebrio</I> larvae, which is shared with lysine-type peptidoglycan-induced Toll pathway activation.</p>
]]></description>
<dc:creator><![CDATA[Roh, K.-B., Kim, C.-H., Lee, H., Kwon, H.-M., Park, J.-W., Ryu, J.-H., Kurokawa, K., Ha, N.-C., Lee, W.-J., Lemaitre, B., Soderhall, K., Lee, B.-L.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.007419</dc:identifier>
<dc:title><![CDATA[Proteolytic Cascade for the Activation of the Insect Toll Pathway Induced by the Fungal Cell Wall Component [Enzyme Catalysis and Regulation]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19481</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19474</prism:startingPage>
<prism:section>Enzyme Catalysis and Regulation</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19482?rss=1">
<title><![CDATA[Constitutive and Regulated Endocytosis of the Glycine Transporter GLYT1b Is Controlled by Ubiquitination [Membrane Transport, Structure, Function, and Biogenesis]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19482?rss=1</link>
<description><![CDATA[
<p>The glycine transporter GLYT1 regulates both glycinergic and glutamatergic neurotransmission by controlling the reuptake of glycine at synapses. Trafficking of GLYT1 to and from the cell surface is critical for its function. Activation of PKC down-regulates the activity of GLYT1 through a mechanism that has so far remained uncharacterized. Here we show that GLYT1b undergoes fast constitutive endocytosis that is accelerated by phorbol esters. Both constitutive and regulated endocytosis occur through a dynamin 2- and clathrin-dependent pathway, accumulating in the transporter in transferrin-containing endosomes. A chimera with the extracellular and transmembrane domains of the nerve growth factor receptor and the COOH-terminal tail of GLYT1 was efficiently internalized through this clathrin pathway, suggesting the presence of molecular determinants for GLYT1b endocytosis in its COOH-terminal tail. Extensive site-directed mutagenesis in this region of the chimera highlighted the involvement of lysine residues in its internalization. In the context of the full-length transporter, lysine 619 played a prominent role in both the constitutive and phorbol 12-myristate 13-acetate-induced endocytosis of GLYT1b, suggesting the involvement of ubiquitin modification of GLYT1b during the internalization process. Indeed, we show that GLYT1b undergoes ubiquitination and that this process is stimulated by phorbol 12-myristate 13-acetate. In addition, this endocytosis is impaired in an ubiquitination-deficient cell line, further evidence that constitutive and regulated endocytosis of GLYT1b is ubiquitin-dependent. It remains to be determined whether GLYT1b recycling might be affected in pathologies involving alterations to the ubiquitin system, thereby interfering with its influence on inhibitory and excitatory neurotransmission.</p>
]]></description>
<dc:creator><![CDATA[Fernandez-Sanchez, E., Martinez-Villarreal, J., Gimenez, C., Zafra, F.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.005165</dc:identifier>
<dc:title><![CDATA[Constitutive and Regulated Endocytosis of the Glycine Transporter GLYT1b Is Controlled by Ubiquitination [Membrane Transport, Structure, Function, and Biogenesis]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19492</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19482</prism:startingPage>
<prism:section>Membrane Transport, Structure, Function, and Biogenesis</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19493?rss=1">
<title><![CDATA[Free Thiol Group of MD-2 as the Target for Inhibition of the Lipopolysaccharide-induced Cell Activation [Mechanisms Of Signal Transduction]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19493?rss=1</link>
<description><![CDATA[
<p>MD-2 is a part of the Toll-like 4 signaling complex with an indispensable role in activation of the lipopolysaccharide (LPS) signaling pathway and thus a suitable target for the therapeutic inhibition of TLR4 signaling. Elucidation of MD-2 structure provides a foundation for rational design of inhibitors that bind to MD-2 and inhibit LPS signaling. Since the hydrophobic binding pocket of MD-2 provides little specificity for inhibitors, we have investigated targeting the solvent-accessible cysteine residue within the hydrophobic binding pocket of MD-2. Compounds with affinity for the hydrophobic pocket that contain a thiol-reactive group, which mediates covalent bond formation with the free cysteine residue of MD-2, were tested. Fluorescent compounds 2-(4'-(iodoacetamido)anilino)naphthalene-6-sulfonic acid and <I>N</I>-pyrene maleimide formed a covalent bond with MD-2 through Cys<sup>133</sup> and inhibited LPS signaling. Cell activation was also inhibited by thiol-reactive compounds JTT-705 originally targeted against cholesterol ester transfer protein and antirheumatic compound auranofin. Oral intake of JTT-705 significantly inhibited endotoxin-triggered tumor necrosis factor  production in mice. The thiol group of MD-2 also represents the target of environmental or endogenous thiol-reactive compounds that are produced in inflammation.</p>
]]></description>
<dc:creator><![CDATA[Mancek-Keber, M., Gradisar, H., Pestana, M. I., de Tejada, G. M., Jerala, R.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.003756</dc:identifier>
<dc:title><![CDATA[Free Thiol Group of MD-2 as the Target for Inhibition of the Lipopolysaccharide-induced Cell Activation [Mechanisms Of Signal Transduction]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19500</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19493</prism:startingPage>
<prism:section>Mechanisms Of Signal Transduction</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19501?rss=1">
<title><![CDATA[Disease Mutations in the Human Mitochondrial DNA Polymerase Thumb Subdomain Impart Severe Defects in Mitochondrial DNA Replication [Dna: Replication, Repair, Recombination, and Chromosome Dynamics]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19501?rss=1</link>
<description><![CDATA[
<p>Forty-five different point mutations in <I>POLG</I>, the gene encoding the catalytic subunit of the human mitochondrial DNA polymerase (pol ), cause the early onset mitochondrial DNA depletion disorder, Alpers syndrome. Sequence analysis of the C-terminal polymerase region of pol  revealed a cluster of four Alpers mutations at highly conserved residues in the thumb subdomain (G848S, c.2542g-&gt;a; T851A, c.2551a-&gt;g; R852C, c.2554c-&gt;t; R853Q, c.2558g-&gt;a) and two Alpers mutations at less conserved positions in the adjacent palm subdomain (Q879H, c.2637g-&gt;t and T885S, c.2653a-&gt;t). Biochemical characterization of purified, recombinant forms of pol  revealed that Alpers mutations in the thumb subdomain reduced polymerase activity more than 99% relative to the wild-type enzyme, whereas the palm subdomain mutations retained 50&ndash;70% wild-type polymerase activity. All six mutant enzymes retained physical and functional interaction with the pol  accessory subunit (p55), and none of the six mutants exhibited defects in misinsertion fidelity <I>in vitro</I>. However, differential DNA binding by these mutants suggests a possible orientation of the DNA with respect to the polymerase during catalysis. To our knowledge this study represents the first structure-function analysis of the thumb subdomain in pol  and examines the consequences of mitochondrial disease mutations in this region.</p>
]]></description>
<dc:creator><![CDATA[Kasiviswanathan, R., Longley, M. J., Chan, S. S. L., Copeland, W. C.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.011940</dc:identifier>
<dc:title><![CDATA[Disease Mutations in the Human Mitochondrial DNA Polymerase Thumb Subdomain Impart Severe Defects in Mitochondrial DNA Replication [Dna: Replication, Repair, Recombination, and Chromosome Dynamics]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19510</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19501</prism:startingPage>
<prism:section>Dna: Replication, Repair, Recombination, and Chromosome Dynamics</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19511?rss=1">
<title><![CDATA[Plasminogen Substrate Recognition by the Streptokinase-Plasminogen Catalytic Complex Is Facilitated by Arg253, Lys256, and Lys257 in the Streptokinase {beta}-Domain and Kringle 5 of the Substrate [Enzyme Catalysis and Regulation]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19511?rss=1</link>
<description><![CDATA[
<p>Streptokinase (SK) conformationally activates the central zymogen of the fibrinolytic system, plasminogen (Pg). The SK&middot;Pg* catalytic complex binds Pg as a specific substrate and cleaves it into plasmin (Pm), which binds SK to form the SK&middot;Pm complex that propagates Pm generation. Catalytic complex formation is dependent on lysine-binding site (LBS) interactions between a Pg/Pm kringle and the SK COOH-terminal Lys<sup>414</sup>. Pg substrate recognition is also LBS-dependent, but the kringle and SK structural element(s) responsible have not been identified. SK mutants lacking Lys<sup>414</sup> with Ala substitutions of charged residues in the SK &beta;-domain 250-loop were evaluated in kinetic studies that resolved conformational and proteolytic Pg activation. Activation of [Lys]Pg and mini-Pg (containing only kringle 5 of Pg) by SK with Ala substitutions of Arg<sup>253</sup>, Lys<sup>256</sup>, and Lys<sup>257</sup> showed decreases in the bimolecular rate constant for Pm generation, with nearly total inhibition for the SK Lys<sup>256</sup>/Lys<sup>257</sup> double mutant. Binding of bovine Pg (BPg) to the SK&middot;Pm complex containing fluorescently labeled Pm demonstrated LBS-dependent assembly of a SK&middot;labeled Pm&middot;BPg ternary complex, whereas BPg did not bind to the complex containing the SK Lys<sup>256</sup>/Lys<sup>257</sup> mutant. BPg was activated by SK&middot;Pm with a <I>K<SUB>m</SUB></I> indistinguishable from the <I>K<SUB>D</SUB></I> for BPg binding to form the ternary complex, whereas the SK Lys<sup>256</sup>/Lys<sup>257</sup> mutant did not support BPg activation. We conclude that SK residues Arg<sup>253</sup>, Lys<sup>256</sup>, and Lys<sup>257</sup> mediate Pg substrate recognition through kringle 5 of the [Lys]Pg and mini-Pg substrates. A molecular model of the SK&middot;kringle 5 complex identifies the putative interactions involved in LBS-dependent Pg substrate recognition.</p>
]]></description>
<dc:creator><![CDATA[Tharp, A. C., Laha, M., Panizzi, P., Thompson, M. W., Fuentes-Prior, P., Bock, P. E.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.005512</dc:identifier>
<dc:title><![CDATA[Plasminogen Substrate Recognition by the Streptokinase-Plasminogen Catalytic Complex Is Facilitated by Arg253, Lys256, and Lys257 in the Streptokinase {beta}-Domain and Kringle 5 of the Substrate [Enzyme Catalysis and Regulation]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19521</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19511</prism:startingPage>
<prism:section>Enzyme Catalysis and Regulation</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19522?rss=1">
<title><![CDATA[The Tether Connecting Cytosolic (N Terminus) and Membrane (C Terminus) Domains of Yeast V-ATPase Subunit a (Vph1) Is Required for Assembly of V0 Subunit d [Membrane Transport, Structure, Function, and Biogenesis]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19522?rss=1</link>
<description><![CDATA[
<p>V-ATPases are molecular motors that reversibly disassemble <I>in vivo</I>. Anchored in the membrane is subunit a. Subunit a has a movable N terminus that switches positions during disassembly and reassembly. Deletions were made at residues securing the N terminus of subunit a (yeast isoform Vph1) to its membrane-bound C-terminal domain in order to understand the role of this conserved region for V-ATPase function. Shrinking of the tether made cells pH-sensitive (<I>vma</I> phenotype) because assembly of V<SUB>0</SUB> subunit d was harmed. Subunit d did not co-immunoprecipitate with subunit a and the c-ring. Cells contained pools of V<SUB>1</SUB> and V<SUB>0</SUB>(&ndash;d) that failed to form V<SUB>1</SUB>V<SUB>0</SUB>, and very low levels of V-ATPase subunits were found at the membrane. Although subunit d expression was stable and at wild-type levels, growth defects were rescued by exogenous <I>VMA6</I> (subunit d). Stable V<SUB>1</SUB>V<SUB>0</SUB> assembled after yeast cells were co-transformed with <I>VMA6</I> and mutant <I>VPH1</I>. Tether-less V<SUB>1</SUB>V<SUB>0</SUB> was delivered to the vacuole and active. It retained 63&ndash;71% of the wild-type activity and was responsive to glucose. Tether-less V<SUB>1</SUB>V<SUB>0</SUB> disassembled and reassembled after brief glucose depletion and readdition. The N terminus retained binding to V<SUB>1</SUB> subunits and the C terminus to phosphofructokinase. Thus, no major structural change was generated at the N and C termini of subunit a. We concluded that early steps of V<SUB>0</SUB> assembly and trafficking were likely impaired by shorter tethers and rescued by <I>VMA6</I>.</p>
]]></description>
<dc:creator><![CDATA[Ediger, B., Melman, S. D., Pappas, D. L., Finch, M., Applen, J., Parra, K. J.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.013375</dc:identifier>
<dc:title><![CDATA[The Tether Connecting Cytosolic (N Terminus) and Membrane (C Terminus) Domains of Yeast V-ATPase Subunit a (Vph1) Is Required for Assembly of V0 Subunit d [Membrane Transport, Structure, Function, and Biogenesis]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19532</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19522</prism:startingPage>
<prism:section>Membrane Transport, Structure, Function, and Biogenesis</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19533?rss=1">
<title><![CDATA[Pirenzepine Promotes the Dimerization of Muscarinic M1 Receptors through a Three-step Binding Process [Mechanisms Of Signal Transduction]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19533?rss=1</link>
<description><![CDATA[
<p>Ligand binding to G protein-coupled receptors is a complex process that involves sequential receptor conformational changes, ligand translocation, and possibly ligand-induced receptor oligomerization. Binding events at muscarinic acetylcholine receptors are usually interpreted from radioligand binding studies in terms of two-step ligand-induced receptor isomerization. We report here, using a combination of fluorescence approaches, on the molecular mechanisms for Bodipy-pirenzepine binding to enhanced green fluorescent protein (EGFP)-fused muscarinic M1 receptors in living cells. Real time monitoring, under steady-state conditions, of the strong fluorescence energy transfer signal elicited by this interaction permitted a fine kinetic description of the binding process. Time-resolved fluorescence measurements allowed us to identify discrete EGFP lifetime species and to follow their redistribution upon ligand binding. Fluorescence correlation spectroscopy, with EGFP brightness analysis, showed that EGFP-fused muscarinic M1 receptors predominate as monomers in the absence of ligand and dimerize upon pirenzepine binding. Finally, all these experimental data could be quantitatively reconciled into a three-step mechanism, with four identified receptor conformational states. Fast ligand binding to a peripheral receptor site initiates a sequence of conformational changes that allows the ligand to access to inner regions of the protein and drives ligand-receptor complexes toward a high affinity dimeric state.</p>
]]></description>
<dc:creator><![CDATA[Ilien, B., Glasser, N., Clamme, J.-P., Didier, P., Piemont, E., Chinnappan, R., Daval, S. B., Galzi, J.-L., Mely, Y.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.017145</dc:identifier>
<dc:title><![CDATA[Pirenzepine Promotes the Dimerization of Muscarinic M1 Receptors through a Three-step Binding Process [Mechanisms Of Signal Transduction]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19543</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19533</prism:startingPage>
<prism:section>Mechanisms Of Signal Transduction</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19544?rss=1">
<title><![CDATA[Differential Regulation of Glycogenolysis by Mutant Protein Phosphatase-1 Glycogen-targeting Subunits [Metabolism and Bioenergetics]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19544?rss=1</link>
<description><![CDATA[
<p>PTG and G<SUB>L</SUB> are hepatic protein phosphatase-1 (PP1) glycogen-targeting subunits, which direct PP1 activity against glycogen synthase (GS) and/or phosphorylase (GP). The C-terminal 16 amino residues of G<SUB>L</SUB> comprise a high affinity binding site for GP that regulates bound PP1 activity against GS. In this study, a truncated G<SUB>L</SUB> construct lacking the GP-binding site (G<SUB>L</SUB>tr) and a chimeric PTG molecule containing the C-terminal site (PTG-G<SUB>L</SUB>) were generated. As expected, GP binding to glutathione S-transferase (GST)-G<SUB>L</SUB>tr was reduced, whereas GP binding to GST-PTG-G<SUB>L</SUB> was increased 2- to 3-fold <I>versus</I> GST-PTG. In contrast, PP1 binding to all proteins was equivalent. Primary mouse hepatocytes were infected with adenoviral constructs for each subunit, and their effects on glycogen metabolism were investigated. G<SUB>L</SUB>tr expression was more effective at promoting GP inactivation, GS activation, and glycogen accumulation than G<SUB>L</SUB>. Removal of the regulatory GP-binding site from G<SUB>L</SUB>tr completely blocked the inactivation of GS seen in G<SUB>L</SUB>-expressing cells following a drop in extracellular glucose. As a result, G<SUB>L</SUB>tr expression prevented glycogen mobilization under 5 m<scp>m</scp> glucose conditions. In contrast, equivalent overexpression of PTG or PTG-G<SUB>L</SUB> caused a similar increase in glycogen-targeted PP1 levels and GS dephosphorylation. Surprisingly, GP dephosphorylation was significantly reduced in PTG-G<SUB>L</SUB>-overexpressing cells. As a result, PTG-G<SUB>L</SUB> expression permitted glycogenolysis under 5 m<scp>m</scp> glucose conditions that was prevented in PTG-expressing cells. Thus, expression of constructs that contained the high affinity GP-binding site (G<SUB>L</SUB> and PTG-G<SUB>L</SUB>) displayed reduced glycogen accumulation and enhanced glycogenolysis compared with their respective controls, albeit via different mechanisms.</p>
]]></description>
<dc:creator><![CDATA[Danos, A. M., Osmanovic, S., Brady, M. J.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.015073</dc:identifier>
<dc:title><![CDATA[Differential Regulation of Glycogenolysis by Mutant Protein Phosphatase-1 Glycogen-targeting Subunits [Metabolism and Bioenergetics]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19553</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19544</prism:startingPage>
<prism:section>Metabolism and Bioenergetics</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19554?rss=1">
<title><![CDATA[The p160 Coactivator PAS-B Motif Stabilizes Nuclear Receptor Binding and Contributes to Isoform-specific Regulation by Thyroid Hormone Receptors [Transcription, Chromatin, and Epigenetics]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19554?rss=1</link>
<description><![CDATA[
<p>Thyroid hormone receptors (TRs) are hormone-regulated transcription factors that play multiple roles in vertebrate endocrinology and development. TRs are expressed as a series of distinct receptor isoforms that mediate different biological functions. The TR&beta;2 isoform is expressed primarily in the hypothalamus, pituitary, cochlea, and retina, and displays an enhanced response to hormone agonist relative to the other TR isoforms. We report here that the unusual transcriptional properties of TR&beta;2 parallel the ability of this isoform to bind p160 coactivators cooperatively through multiple contact surfaces; the more broadly expressed TR&beta;1 isoform, in contrast, utilizes a single contact mechanism. Intriguingly, the PAS-B domain in the p160 N terminus plays a previously unanticipated role in permitting TR&beta;2 to recruit coactivator at limiting triiodothyronine concentrations. The PAS-B sequences also play an important role in coactivator binding by estrogen receptor-. We propose that the PAS-B domain of the p160 coactivators is an important modulator of coactivator recruitment for a specific subset of nuclear receptors, permitting stronger transcriptional activation at lower hormone concentrations than would otherwise occur, and allowing isoform-specific mRNA splicing to customize the hormone response in different tissues.</p>
]]></description>
<dc:creator><![CDATA[Privalsky, M. L., Lee, S., Hahm, J. B., Young, B. M., Fong, R. N. G., Chan, I. H.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.007542</dc:identifier>
<dc:title><![CDATA[The p160 Coactivator PAS-B Motif Stabilizes Nuclear Receptor Binding and Contributes to Isoform-specific Regulation by Thyroid Hormone Receptors [Transcription, Chromatin, and Epigenetics]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19563</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19554</prism:startingPage>
<prism:section>Transcription, Chromatin, and Epigenetics</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19564?rss=1">
<title><![CDATA[GRK5 Deficiency Leads to Reduced Hippocampal Acetylcholine Level via Impaired Presynaptic M2/M4 Autoreceptor Desensitization [Mechanisms Of Signal Transduction]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19564?rss=1</link>
<description><![CDATA[
<p>G protein-coupled receptor kinase 5 (GRK5) deficiency has been linked recently to early Alzheimer disease (AD), but the mechanism by which GRK5 deficiency may contribute to AD pathogenesis remains elusive. Here we report that overexpression of dominant negative mutant of GRK5 (dnGRK5) in a cholinergic neuronal cell line led to decreased acetylcholine (ACh) release. This reduction was fully corrected by pertussis toxin, atropine (a nonselective muscarinic antagonist), or methoctramine (a selective M2/M4 muscarinic receptor antagonist). Consistent with results in cultured cells, high potassium-evoked ACh release in hippocampal slices from young GRK5 knock-out mice was significantly reduced compared with wild type littermates, and this reduced ACh release was also fully corrected by methoctramine. In addition, following treatment with the nonselective muscarinic agonist oxotremorine-M, M2, and M4 receptors underwent significantly reduced internalization in GRK5KO slices compared with wild type slices, as assessed by plasma membrane retention of receptor immunoreactivity, whereas M1 receptor internalization was not affected by loss of GRK5 expression. Moreover, Western blotting revealed no synaptic or cholinergic degenerative changes in young GRK5 knock-out mice. Altogether, these results suggest that GRK5 deficiency leads to a reduced hippocampal ACh release and cholinergic hypofunction by selective impairment of desensitization of presynaptic M2/M4 autoreceptors. Because this nonstructural cholinergic hypofunction precedes the hippocampal cholinergic hypofunction associated with structural cholinergic degeneration and cognitive decline in aged GRK5 knock-out mice, this nonstructural alteration may be an early event contributing to cholinergic degeneration in AD.</p>
]]></description>
<dc:creator><![CDATA[Liu, J., Rasul, I., Sun, Y., Wu, G., Li, L., Premont, R. T., Suo, W. Z.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.005959</dc:identifier>
<dc:title><![CDATA[GRK5 Deficiency Leads to Reduced Hippocampal Acetylcholine Level via Impaired Presynaptic M2/M4 Autoreceptor Desensitization [Mechanisms Of Signal Transduction]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19571</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19564</prism:startingPage>
<prism:section>Mechanisms Of Signal Transduction</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19572?rss=1">
<title><![CDATA[The X-ray Structure of RU486 Bound to the Progesterone Receptor in a Destabilized Agonistic Conformation [Protein Structure and Folding]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19572?rss=1</link>
<description><![CDATA[
<p>Here we describe the 1.95 &Aring; structure of the clinically used antiprogestin RU486 (mifepristone) in complex with the progesterone receptor (PR). The structure was obtained by taking a crystal of the PR ligand binding domain containing the agonist norethindrone and soaking it in a solution containing the antagonist RU486 for extended times. Clear ligand exchange could be observed in one copy of the PR ligand binding domain dimer in the crystal. RU486 binds while PR is in an agonistic conformation without displacing helix 12. Although this is probably because of the constraints of the crystal lattice, it demonstrates that helix 12 displacement is not a prerequisite for RU486 binding. Interestingly, B-factor analysis clearly shows that helix 12 becomes more flexible after RU486 binding, suggesting that RU486, being a model antagonist, does not induce one fixed conformation of helix 12 but changes its positional equilibrium. This conclusion is confirmed by comparing the structures of RU486 bound to PR and RU486 bound to the glucocorticoid receptor.</p>
]]></description>
<dc:creator><![CDATA[Raaijmakers, H. C. A., Versteegh, J. E., Uitdehaag, J. C. M.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.007872</dc:identifier>
<dc:title><![CDATA[The X-ray Structure of RU486 Bound to the Progesterone Receptor in a Destabilized Agonistic Conformation [Protein Structure and Folding]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19579</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19572</prism:startingPage>
<prism:section>Protein Structure and Folding</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19580?rss=1">
<title><![CDATA[Corneal Dystrophy-associated R124H Mutation Disrupts TGFBI Interaction with Periostin and Causes Mislocalization to the Lysosome [Glycobiology and Extracellular Matrices]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19580?rss=1</link>
<description><![CDATA[
<p>The 5q31-linked corneal dystrophies are heterogeneous autosomal-dominant eye disorders pathologically characterized by the progressive accumulation of aggregated proteinaceous deposits in the cornea, which manifests clinically as severe vision impairment. The 5q31-linked corneal dystrophies are commonly caused by mutations in the <I>TGFBI</I> (<unl>t</unl>ransforming <unl>g</unl>rowth <unl>f</unl>actor-<unl>&beta;</unl>-<unl>i</unl>nduced) gene. However, despite the identification of the culprit gene, the cellular roles of TGFBI and the molecular mechanisms underlying the pathogenesis of corneal dystrophy remain poorly understood. Here we report the identification of periostin, a molecule that is highly related to TGFBI, as a specific TGFBI-binding partner. The association of TGFBI and periostin is mediated by the amino-terminal cysteine-rich EMI domains of TGFBI and periostin. Our results indicate that the endogenous TGFBI and periostin colocalize within the <I>trans</I>-Golgi network and associate prior to secretion. The corneal dystrophy-associated R124H mutation in TGFBI severely impairs interaction with periostin <I>in vivo</I>. In addition, the R124H mutation causes aberrant redistribution of the mutant TGFBI into lysosomes. We also find that the periostin-TGFBI interaction is disrupted in corneal fibroblasts cultured from granular corneal dystrophy type II patients and that periostin accumulates in TGFBI-positive corneal deposits in granular corneal dystrophy type II (also known as Avellino corneal dystrophy). Together, our findings suggest that TGFBI and periostin may play cooperative cellular roles and that periostin may be involved in the pathogenesis of 5q31-linked corneal dystrophies.</p>
]]></description>
<dc:creator><![CDATA[Kim, B.-Y., Olzmann, J. A., Choi, S.-i., Ahn, S. Y., Kim, T.-i., Cho, H.-S., Suh, H., Kim, E. K.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.013607</dc:identifier>
<dc:title><![CDATA[Corneal Dystrophy-associated R124H Mutation Disrupts TGFBI Interaction with Periostin and Causes Mislocalization to the Lysosome [Glycobiology and Extracellular Matrices]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19591</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19580</prism:startingPage>
<prism:section>Glycobiology and Extracellular Matrices</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19592?rss=1">
<title><![CDATA[SUMO Interaction Motifs in Sizn1 Are Required for Promyelocytic Leukemia Protein Nuclear Body Localization and for Transcriptional Activation [Molecular Basis Of Cell and Developmental Biology]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19592?rss=1</link>
<description><![CDATA[
<p>Mutations in Sizn1 (Zcchc12), a novel transcriptional co-activator in the BMP signaling pathway, are associated with X-linked mental retardation. Previously, we demonstrated that Sizn1 positively modulates the BMP signal by interacting with Smad family members and cAMP-responsive element-binding protein-binding protein. To further define the molecular basis of Sizn1 function, we have explored its subcellular localization and generated various deletion mutants to carry out domain analyses. Here, we report that Sizn1 localizes to promyelocytic leukemia protein nuclear bodies (PML-NBs). Sizn1 deletion mutants that disrupt the MA homologous domain or the middle region fail to target to the PML-NB. We show that two SUMO interaction motifs (SIMs) in Sizn1 can bind to SUMO and govern SUMO conjugation to Sizn1 in the absence of the consensus motif for SUMO attachment. Interestingly, the SIM mutant Sizn1 localizes to nuclear bodies, but not to PML-NBs. Thus, SIMs mediate the localization of Sizn1 to PML-NB. Interestingly, mutations in SIM sequences and deletion of the MA homologous domain also affected the transcriptional co-activation function of a Sizn1. Taken together, our data indicate that the SIMs in Sizn1 are required for its PML-NB localization and for the full transcriptional co-activation function in BMP signaling.</p>
]]></description>
<dc:creator><![CDATA[Cho, G., Lim, Y., Golden, J. A.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.010181</dc:identifier>
<dc:title><![CDATA[SUMO Interaction Motifs in Sizn1 Are Required for Promyelocytic Leukemia Protein Nuclear Body Localization and for Transcriptional Activation [Molecular Basis Of Cell and Developmental Biology]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19600</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19592</prism:startingPage>
<prism:section>Molecular Basis Of Cell and Developmental Biology</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19601?rss=1">
<title><![CDATA[Rpb9 Subunit Controls Transcription Fidelity by Delaying NTP Sequestration in RNA Polymerase II [Enzyme Catalysis and Regulation]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19601?rss=1</link>
<description><![CDATA[
<p>Rpb9 is a small non-essential subunit of yeast RNA polymerase II located on the surface on the enzyme. Deletion of the <I>RPB9</I> gene shows synthetic lethality with the low fidelity <I>rpb1-E1103G</I> mutation localized in the trigger loop, a mobile element of the catalytic Rpb1 subunit, which has been shown to control transcription fidelity. Similar to the <I>rpb1-E1103G</I> mutation, the <I>RPB9</I> deletion substantially enhances NTP misincorporation and increases the rate of mismatch extension with the next cognate NTP <I>in vitro</I>. Using pre-steady state kinetic analysis, we show that <I>RPB9</I> deletion promotes sequestration of NTPs in the polymerase active center just prior to the phosphodiester bond formation. We propose a model in which the Rpb9 subunit controls transcription fidelity by delaying the closure of the trigger loop on the incoming NTP via interaction between the C-terminal domain of Rpb9 and the trigger loop. Our findings reveal a mechanism for regulation of transcription fidelity by protein factors located at a large distance from the active center of RNA polymerase II.</p>
]]></description>
<dc:creator><![CDATA[Walmacq, C., Kireeva, M. L., Irvin, J., Nedialkov, Y., Lubkowska, L., Malagon, F., Strathern, J. N., Kashlev, M.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.006908</dc:identifier>
<dc:title><![CDATA[Rpb9 Subunit Controls Transcription Fidelity by Delaying NTP Sequestration in RNA Polymerase II [Enzyme Catalysis and Regulation]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19612</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19601</prism:startingPage>
<prism:section>Enzyme Catalysis and Regulation</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19613?rss=1">
<title><![CDATA[MAD2B, a Novel TCF4-binding Protein, Modulates TCF4-mediated Epithelial-Mesenchymal Transdifferentiation [Mechanisms Of Signal Transduction]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19613?rss=1</link>
<description><![CDATA[
<p>T cell factor 4 (TCF4) interacts with &beta;-catenin in the WNT signaling pathway and transactivates downstream target genes involved in cancer progression. To identify proteins that regulate TCF4-mediated biological responses, we performed a yeast two-hybrid screen to search for a TCF4-binding protein(s) and found that MAD2B interacts with TCF4. We confirmed that MAD2B is a TCF4-binding protein by co-immunoprecipitation. Using the TOPFLASH reporter assay, we found that MAD2B blocks TCF4-mediated transactivation. The MAD2B binding regions of TCF4 were identified by TCF4 deletion mapping and electrophoretic mobility shift assay analysis. TCF4 and MAD2B interactions abolished the DNA binding ability of TCF4. Knockdown of MAD2B in SW480 colorectal cancer cells led to the conversion of epithelial cells to a mesenchymal fibroblastoid phenotype (epithelial-mesenchymal transdifferentiation). An E-cadherin promoter reporter analysis showed that MAD2B modulates TCF4-mediated E-cadherin expression. MAD2B knockdown blocked E-cadherin expression and significantly induced mesenchymal markers, such as N-cadherin and vimentin. Mesenchymal induction was accompanied by F-actin redistribution and the appearance of a fibroblastoid phenotype. MAD2B knockdown also increased both mRNA and protein levels of Slug, a known TCF4-induced E-cadherin transcriptional repressor. A chromatin immunoprecipitation assay showed that MAD2B silencing enhances the ability of TCF4 to bind the Slug promoter. Thus, MAD2B is a novel TCF4-interacting protein. This study provides the first evidence for the involvement of MAD2B in TCF4-mediated epithelial-mesenchymal transdifferentiation.</p>
]]></description>
<dc:creator><![CDATA[Hong, C.-F., Chou, Y.-T., Lin, Y.-S., Wu, C.-W.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.005017</dc:identifier>
<dc:title><![CDATA[MAD2B, a Novel TCF4-binding Protein, Modulates TCF4-mediated Epithelial-Mesenchymal Transdifferentiation [Mechanisms Of Signal Transduction]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19622</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19613</prism:startingPage>
<prism:section>Mechanisms Of Signal Transduction</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19623?rss=1">
<title><![CDATA[Sprouty2 Interacts with Protein Kinase C{delta} and Disrupts Phosphorylation of Protein Kinase D1 [Mechanisms Of Signal Transduction]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19623?rss=1</link>
<description><![CDATA[
<p>The Sprouty (Spry) proteins act as inhibitors of the Ras/ERK pathway downstream of receptor tyrosine kinases. In this study, we report a novel interaction between protein kinase C  (PKC) and Spry2. Endogenous PKC and Spry2 interact in cells upon basic fibroblast growth factor stimulation, indicating a physiological relevance for the interaction. This interaction appeared to require the full-length Spry2 protein and was conformation-dependent. Conformational constraints were released upon FGFR1 activation, allowing the interaction to occur. Although this interaction did not affect the phosphorylation of PKC by another kinase, it reduced the phosphorylation of a PKC substrate, protein kinase D1 (PKD1). Spry2 was found to interact more strongly with PKC with increasing amounts of PKD1, which indicated that instead of competing with PKD1 for binding with PKC, it was more likely to form a trimeric complex with both PKC and PKD1. Formation of the complex was found to be dependent on an existing PKC-PKD1 interaction. By disrupting the interaction between PKC and PKD1, Spry2 was unable to associate with PKC to form the trimeric complex. As a consequence of this trimeric complex, the existing interaction between PKC and PKD1 was increased, and the transfer of phosphate groups from PKC to PKD1 was at least partly blocked by Spry2. The action of Spry2 on PKC resulted in the inhibition of both ERK phosphorylation and invasion of PC-3 cells via PKC signaling. By disrupting the capacity of PKC to phosphorylate its cognate substrates, Spry2 may serve to modulate PKC signaling downstream of receptor tyrosine kinases and to regulate the physiological outcome.</p>
]]></description>
<dc:creator><![CDATA[Chow, S. Y., Yu, C. Y., Guy, G. R.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.021600</dc:identifier>
<dc:title><![CDATA[Sprouty2 Interacts with Protein Kinase C{delta} and Disrupts Phosphorylation of Protein Kinase D1 [Mechanisms Of Signal Transduction]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19636</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19623</prism:startingPage>
<prism:section>Mechanisms Of Signal Transduction</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19637?rss=1">
<title><![CDATA[Solution Structure of Factor I-like Modules from Complement C7 Reveals a Pair of Follistatin Domains in Compact Pseudosymmetric Arrangement [Protein Structure and Folding]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19637?rss=1</link>
<description><![CDATA[
<p>Factor I-like modules (FIMs) of complement proteins C6, C7, and factor I participate in protein-protein interactions critical to the progress of a complement-mediated immune response to infections and other trauma. For instance, the carboxyl-terminal FIM pair of C7 (C7-FIMs) binds to the C345C domain of C5 and its activated product, C5b, during self-assembly of the cytolytic membrane-attack complex. FIMs share sequence similarity with follistatin domains (FDs) of known three-dimensional structure, suggesting that FIM structures could be reliably modeled. However, conflicting disulfide maps, inconsistent orientations of subdomains within FDs, and the presence of binding partners in all FD structures led us to determine the three-dimensional structure of C7-FIMs by NMR spectroscopy. The solution structure reveals that each FIM within C7 contains a small amino-terminal FOLN subdomain connected to a larger carboxyl-terminal KAZAL domain. The open arrangement of the subdomains within FIMs resembles that of first FDs within structures of tandem FDs but differs from the more compact subdomain arrangement of second or third FDs. Unexpectedly, the two C7-FIMs pack closely together with an approximate 2-fold rotational symmetry that is rarely seen in module pairs and has not been observed in FD-containing proteins. Interfaces between subdomains and between modules include numerous hydrophobic and electrostatic contributions, suggesting that this is a physiologically relevant conformation that persists in the context of the parent protein. Similar interfaces were predicted in a homology-based model of the C6-FIM pair. The C7-FIM structures also facilitated construction of a model of the single FIM of factor I.</p>
]]></description>
<dc:creator><![CDATA[Phelan, M. M., Thai, C.-T., Soares, D. C., Ogata, R. T., Barlow, P. N., Bramham, J.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M901993200</dc:identifier>
<dc:title><![CDATA[Solution Structure of Factor I-like Modules from Complement C7 Reveals a Pair of Follistatin Domains in Compact Pseudosymmetric Arrangement [Protein Structure and Folding]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19649</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19637</prism:startingPage>
<prism:section>Protein Structure and Folding</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19650?rss=1">
<title><![CDATA[Differential Enzymatic Activity of Common Haplotypic Versions of the Human Acidic Mammalian Chitinase Protein [Enzyme Catalysis and Regulation]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19650?rss=1</link>
<description><![CDATA[
<p>Mouse models have shown the importance of acidic mammalian chitinase activity in settings of chitin exposure and allergic inflammation. However, little is known regarding genetic regulation of AMCase enzymatic activity in human allergic diseases. Resequencing the <I>AMCase</I> gene exons we identified 8 non-synonymous single nucleotide polymorphisms including three novel variants (A290G, G296A, G339T) near the gene area coding for the enzyme active site, all in linkage disequilibrium. AMCase protein isoforms, encoded by two gene-wide haplotypes, and differentiated by these three single nucleotide polymorphisms, were recombinantly expressed and purified. Biochemical analysis revealed the isoform encoded by the variant haplotype displayed a distinct pH profile exhibiting greater retention of chitinase activity at acidic and basic pH values. Determination of absolute kinetic activity found the variant isoform encoded by the variant haplotype was 4-, 2.5-, and 10-fold more active than the wild type AMCase isoform at pH 2.2, 4.6, and 7.0, respectively. Modeling of the AMCase isoforms revealed positional changes in amino acids critical for both pH specificity and substrate binding. Genetic association analyses of <I>AMCase</I> haplotypes for asthma revealed significant protective associations between the variant haplotype in several asthma cohorts. The structural, kinetic, and genetic data regarding the AMCase isoforms are consistent with the Th2-priming effects of environmental chitin and a role for AMCase in negatively regulating this stimulus.</p>
]]></description>
<dc:creator><![CDATA[Seibold, M. A., Reese, T. A., Choudhry, S., Salam, M. T., Beckman, K., Eng, C., Atakilit, A., Meade, K., Lenoir, M., Watson, H. G., Thyne, S., Kumar, R., Weiss, K. B., Grammer, L. C., Avila, P., Schleimer, R. P., Fahy, J. V., Rodriguez-Santana, J., Rodriguez-Cintron, W., Boot, R. G., Sheppard, D., Gilliland, F. D., Locksley, R. M., Burchard, E. G.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.012443</dc:identifier>
<dc:title><![CDATA[Differential Enzymatic Activity of Common Haplotypic Versions of the Human Acidic Mammalian Chitinase Protein [Enzyme Catalysis and Regulation]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19658</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19650</prism:startingPage>
<prism:section>Enzyme Catalysis and Regulation</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19659?rss=1">
<title><![CDATA[Crystal Structure of Iodotyrosine Deiodinase, a Novel Flavoprotein Responsible for Iodide Salvage in Thyroid Glands [Protein Structure and Folding]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19659?rss=1</link>
<description><![CDATA[
<p>The flavoprotein iodotyrosine deiodinase (IYD) salvages iodide from mono- and diiodotyrosine formed during the biosynthesis of the thyroid hormone thyroxine. Expression of a soluble domain of this membrane-bound enzyme provided sufficient material for crystallization and characterization by x-ray diffraction. The structures of IYD and two co-crystals containing substrates, mono- and diiodotyrosine, alternatively, were solved at resolutions of 2.0, 2.45, and 2.6 &Aring;, respectively. The structure of IYD is homologous to others in the NADH oxidase/flavin reductase superfamily, but the position of the active site lid in IYD defines a new subfamily within this group that includes BluB, an enzyme associated with vitamin B<SUB>12</SUB> biosynthesis. IYD and BluB also share key interactions involving their bound flavin mononucleotide that suggest a unique catalytic behavior within the superfamily. Substrate coordination to IYD induces formation of an additional helix and coil that act as an active site lid to shield the resulting substrate&middot;flavin complex from solvent. This complex is stabilized by aromatic stacking and extensive hydrogen bonding between the substrate and flavin. The carbon-iodine bond of the substrate is positioned directly over the C-4a/N-5 region of the flavin to promote electron transfer. These structures now also provide a molecular basis for understanding thyroid disease based on mutations of IYD.</p>
]]></description>
<dc:creator><![CDATA[Thomas, S. R., McTamney, P. M., Adler, J. M., LaRonde-LeBlanc, N., Rokita, S. E.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.013458</dc:identifier>
<dc:title><![CDATA[Crystal Structure of Iodotyrosine Deiodinase, a Novel Flavoprotein Responsible for Iodide Salvage in Thyroid Glands [Protein Structure and Folding]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19667</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19659</prism:startingPage>
<prism:section>Protein Structure and Folding</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19668?rss=1">
<title><![CDATA[Alternative Translation Initiation Generates Cytoplasmic Sheep Prion Protein [Protein Synthesis, Post-Translational Modification, and Degradation]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19668?rss=1</link>
<description><![CDATA[
<p>Cytoplasmic localization of the prion protein (PrP) has been observed in different species and cell types. We have investigated this poorly understood phenomenon by expressing fusion proteins of sheep prion protein and green fluorescent protein (<sup>GFP</sup>PrP) in N2a cells, with variable sequence context surrounding the start codon Met<sup>1</sup>. <sup>GFP</sup>PrP expressed with the wild-type sequence was transported normally through the secretory pathway to the cell surface with acquisition of <I>N</I>-glycan groups, but two N-terminal fragments of <sup>GFP</sup>PrP were detected intracellularly, starting in frame from Met<sup>17</sup>. When <sup>GFP</sup>PrP was expressed with a compromised Kozak sequence (<sup>GFP</sup>PrP*), dispersed intracellular fluorescence was observed. A similar switch from pericellular to intracellular PrP localization was seen when analogous constructs of sheep PrP, without inserted GFP, were expressed, showing that this phenomenon is not caused by the GFP tag. Western blotting revealed a reduction in glycosylated forms of <sup>GFP</sup>PrP*, whereas the N-terminal fragments starting from Met<sup>17</sup> were still present. Formation of these N-terminal fragments was completely abolished when Met<sup>17</sup> was replaced by Thr, indicating that leaky ribosomal scanning occurs for normal sheep PrP and that translation from Met<sup>17</sup> is the cause of the aberrant cytoplasmic localization observed for a fraction of the protein. In contrast, the same phenomenon was not detected upon expression of similar constructs for mouse PrP. Analysis of samples from sheep brain allowed immunological detection of N-terminal PrP fragments, indicating that sheep PrP is subject to similar processing mechanisms <I>in vivo</I>.</p>
]]></description>
<dc:creator><![CDATA[Lund, C., Olsen, C. M., Skogtvedt, S., Tveit, H., Prydz, K., Tranulis, M. A.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.003566</dc:identifier>
<dc:title><![CDATA[Alternative Translation Initiation Generates Cytoplasmic Sheep Prion Protein [Protein Synthesis, Post-Translational Modification, and Degradation]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19678</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19668</prism:startingPage>
<prism:section>Protein Synthesis, Post-Translational Modification, and Degradation</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19679?rss=1">
<title><![CDATA[Cardiotrophin-1 Maintains the Undifferentiated State in Skeletal Myoblasts [Molecular Basis Of Cell and Developmental Biology]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19679?rss=1</link>
<description><![CDATA[
<p>Skeletal myogenesis is potently regulated by the extracellular milieu of growth factors and cytokines. We observed that cardiotrophin-1 (CT-1), a member of the interleukin-6 (IL-6) family of cytokines, is a potent regulator of skeletal muscle differentiation. The normal up-regulation of myogenic marker genes, myosin heavy chain (MyHC), myogenic regulatory factors (MRFs), and myocyte enhancer factor 2s (MEF2s) were inhibited by CT-1 treatment. CT-1 also represses myogenin (MyoG) promoter activation. CT-1 activated two signaling pathways: signal transducer and activator of transcription 3 (STAT3), and mitogen-activated protein kinase kinase (MEK), a component of the extracellular signal-regulated MAPK (ERK) pathway. In view of the known connection between CT-1 and STAT3 activation, we surprisingly found that pharmacological blockade of STAT3 activity had no effect on the inhibition of myogenesis by CT-1 suggesting that STAT3 signaling is dispensable for myogenic repression. Conversely, MEK inhibition potently reversed the inhibition of myotube formation and attenuated the repression of MRF transcriptional activity mediated by CT-1. Taken together, these data indicate that CT-1 represses skeletal myogenesis through interference with MRF activity by activation of MEK/ERK signaling. In agreement with these <I>in vitro</I> observations, exogenous systemic expression of CT-1 mediated by adenoviral vector delivery increased the number of myonuclei in normal post-natal mouse skeletal muscle and also delayed skeletal muscle regeneration induced by cardiotoxin injection. The expression pattern of CT-1 in embryonic and post-natal skeletal muscle and <I>in vivo</I> effects of CT-1 on myogenesis implicate CT-1 in the maintenance of the undifferentiated state in muscle progenitor cells.</p>
]]></description>
<dc:creator><![CDATA[Miyake, T., Alli, N. S., Aziz, A., Knudson, J., Fernando, P., Megeney, L. A., McDermott, J. C.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.017319</dc:identifier>
<dc:title><![CDATA[Cardiotrophin-1 Maintains the Undifferentiated State in Skeletal Myoblasts [Molecular Basis Of Cell and Developmental Biology]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19693</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19679</prism:startingPage>
<prism:section>Molecular Basis Of Cell and Developmental Biology</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19694?rss=1">
<title><![CDATA[Interdependence of Laminin-mediated Clustering of Lipid Rafts and the Dystrophin Complex in Astrocytes [Molecular Basis Of Cell and Developmental Biology]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19694?rss=1</link>
<description><![CDATA[
<p>Astrocyte endfeet surrounding blood vessels are active domains involved in water and potassium ion transport crucial to the maintenance of water and potassium ion homeostasis in brain. A growing body of evidence points to a role for dystroglycan and its interaction with perivascular laminin in the targeting of the dystrophin complex and the water-permeable channel, aquaporin 4 (AQP4), at astrocyte endfeet. However, the mechanisms underlying such compartmentalization remain poorly understood. In the present study we found that AQP4 resided in Triton X-100-insoluble fraction, whereas dystroglycan was recovered in the soluble fraction in astrocytes. Cholesterol depletion resulted in the translocation of a pool of AQP4 to the soluble fraction indicating that its distribution is indeed associated with cholesterol-rich membrane domains. Upon laminin treatment AQP4 and the dystrophin complex, including dystroglycan, reorganized into laminin-associated clusters enriched for the lipid raft markers GM1 and flotillin-1 but not caveolin-1. Reduced diffusion rates of GM1 in the laminin-induced clusters were indicative of the reorganization of raft components in these domains. In addition, both cholesterol depletion and dystroglycan silencing reduced the number and area of laminin-induced clusters of GM1, AQP4, and dystroglycan. These findings demonstrate the interdependence between laminin binding to dystroglycan and GM1-containing lipid raft reorganization and provide novel insight into the dystrophin complex regulation of AQP4 polarization in astrocytes.</p>
]]></description>
<dc:creator><![CDATA[Noel, G., Tham, D. K. L., Moukhles, H.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.010090</dc:identifier>
<dc:title><![CDATA[Interdependence of Laminin-mediated Clustering of Lipid Rafts and the Dystrophin Complex in Astrocytes [Molecular Basis Of Cell and Developmental Biology]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19704</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19694</prism:startingPage>
<prism:section>Molecular Basis Of Cell and Developmental Biology</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19705?rss=1">
<title><![CDATA[A Role for HSP70 in Protecting against Indomethacin-induced Gastric Lesions [Mechanisms Of Signal Transduction]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19705?rss=1</link>
<description><![CDATA[
<p>A major clinical problem encountered with the use of nonsteroidal anti-inflammatory drugs (NSAIDs), such as indomethacin, is gastrointestinal complications. Both NSAID-dependent cyclooxygenase inhibition and gastric mucosal apoptosis are involved in NSAID-produced gastric lesions, and this apoptosis is mediated by the endoplasmic reticulum stress response and resulting activation of Bax. Heat shock proteins (HSPs) have been suggested to protect gastric mucosa from NSAID-induced lesions; here we have tested this idea genetically. The severity of gastric lesions produced by indomethacin was worse in mice lacking heat shock factor 1 (HSF1), a transcription factor for <I>hsp</I> genes, than in control mice. Indomethacin administration up-regulated the expression of gastric mucosal HSP70. Indomethacin-induced gastric lesions were ameliorated in transgenic mice expressing HSP70. After indomethacin administration, fewer apoptotic cells were observed in the gastric mucosa of transgenic mice expressing HSP70 than in wild-type mice, whereas the gastric levels of prostaglandin E<SUB>2</SUB> for the two were indistinguishable. This suggests that expression of HSP70 ameliorates indomethacin-induced gastric lesions by affecting mucosal apoptosis. Suppression of HSP70 expression <I>in vitro</I> stimulated indomethacin-induced apoptosis and activation of Bax but not the endoplasmic reticulum stress response. Geranylgeranylacetone induced HSP70 at gastric mucosa in an HSF1-dependent manner and suppressed the formation of indomethacin-induced gastric lesions in wild-type mice but not in HSF1-null mice. The results of this study provide direct genetic evidence that expression of HSP70 confers gastric protection against indomethacin-induced lesions by inhibiting the activation of Bax. The HSP inducing activity of geranylgeranylacetone seems to contribute to its gastroprotective activity against indomethacin.</p>
]]></description>
<dc:creator><![CDATA[Suemasu, S., Tanaka, K.-I., Namba, T., Ishihara, T., Katsu, T., Fujimoto, M., Adachi, H., Sobue, G., Takeuchi, K., Nakai, A., Mizushima, T.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.006817</dc:identifier>
<dc:title><![CDATA[A Role for HSP70 in Protecting against Indomethacin-induced Gastric Lesions [Mechanisms Of Signal Transduction]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19715</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19705</prism:startingPage>
<prism:section>Mechanisms Of Signal Transduction</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19716?rss=1">
<title><![CDATA[Functions of Manduca sexta Hemolymph Proteinases HP6 and HP8 in Two Innate Immune Pathways [Enzyme Catalysis and Regulation]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19716?rss=1</link>
<description><![CDATA[
<p>Serine proteinases in insect plasma have been implicated in two types of immune responses; that is, activation of prophenoloxidase (proPO) and activation of cytokine-like proteins. We have identified more than 20 serine proteinases in hemolymph of the tobacco hornworm, <I>Manduca sexta</I>, but functions are known for only a few of them. We report here functions of two additional <I>M. sexta</I> proteinases, hemolymph proteinases 6 and 8 (HP6 and HP8). HP6 and HP8 are each composed of an amino-terminal clip domain and a carboxyl-terminal proteinase domain. HP6 is an apparent ortholog of <I>Drosophila</I> Persephone, whereas HP8 is most similar to <I>Drosophila</I> and <I>Tenebrio</I> sp&auml;tzle-activating enzymes, all of which activate the Toll pathway. proHP6 and proHP8 are expressed constitutively in fat body and hemocytes and secreted into plasma, where they are activated by proteolytic cleavage in response to infection. To investigate activation and biological activity of HP6 and HP8, we purified recombinant proHP8, proHP6, and mutants of proHP6 in which the catalytic serine was replaced with alanine, and/or the activation site was changed to permit activation by bovine factor Xa. HP6 was found to activate proPO-activating proteinase (proPAP1) <I>in vitro</I> and induce proPO activation in plasma. HP6 was also determined to activate proHP8. Active HP6 or HP8 injected into larvae induced expression of antimicrobial peptides and proteins, including attacin, cecropin, gloverin, moricin, and lysozyme. Our results suggest that proHP6 becomes activated in response to microbial infection and participates in two immune pathways; activation of PAP1, which leads to proPO activation and melanin synthesis, and activation of HP8, which stimulates a Toll-like pathway.</p>
]]></description>
<dc:creator><![CDATA[An, C., Ishibashi, J., Ragan, E. J., Jiang, H., Kanost, M. R.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.007112</dc:identifier>
<dc:title><![CDATA[Functions of Manduca sexta Hemolymph Proteinases HP6 and HP8 in Two Innate Immune Pathways [Enzyme Catalysis and Regulation]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19726</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19716</prism:startingPage>
<prism:section>Enzyme Catalysis and Regulation</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19727?rss=1">
<title><![CDATA[Endosomal Trafficking of HIV-1 Gag and Genomic RNAs Regulates Viral Egress [Molecular Basis Of Cell and Developmental Biology]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19727?rss=1</link>
<description><![CDATA[
<p>HIV-1 Gag can assemble and generate virions at the plasma membrane, but it is also present in endosomes where its role remains incompletely characterized. Here, we show that HIV-1 RNAs and Gag are transported on endosomal vesicles positive for TiVamp, a v-SNARE involved in fusion events with the plasma membrane. Inhibition of endosomal traffic did not prevent viral release. However, inhibiting lysosomal degradation induced an accumulation of Gag in endosomes and increased viral production 7-fold, indicating that transport of Gag to lysosomes negatively regulates budding. This also suggested that endosomal Gag-RNA complexes could access retrograde pathways to the cell surface and indeed, depleting cells of TiVamp-reduced viral production. Moreover, inhibition of endosomal transport prevented the accumulation of Gag at sites of cellular contact. HIV-1 Gag could thus generate virions using two pathways, either directly from the plasma membrane or through an endosome-dependent route. Endosomal Gag-RNA complexes may be delivered at specific sites to facilitate cell-to-cell viral transmission.</p>
]]></description>
<dc:creator><![CDATA[Molle, D., Segura-Morales, C., Camus, G., Berlioz-Torrent, C., Kjems, J., Basyuk, E., Bertrand, E.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.019844</dc:identifier>
<dc:title><![CDATA[Endosomal Trafficking of HIV-1 Gag and Genomic RNAs Regulates Viral Egress [Molecular Basis Of Cell and Developmental Biology]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19743</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19727</prism:startingPage>
<prism:section>Molecular Basis Of Cell and Developmental Biology</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19744?rss=1">
<title><![CDATA[Intestinal Anion Exchanger Down-regulated in Adenoma (DRA) Is Inhibited by Intracellular Calcium [Membrane Transport, Structure, Function, and Biogenesis]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19744?rss=1</link>
<description><![CDATA[
<p>The Na/H exchanger 3 (NHE3) and the Cl/HCO<SUB>3</SUB> exchanger down-regulated in adenoma (DRA) together facilitate intestinal electroneutral NaCl absorption. Elevated Ca<sup>2+</sup><I><SUB>i</SUB></I> inhibits NHE3 through mechanisms involving the PDZ domain proteins NHE3 kinase A regulatory protein (E3KARP) or PDZ kidney 1 (PDZK1). DRA also possesses a PDZ-binding motif, but the roles of interactions with E3KARP or PDZK1 and Ca<sup>2+</sup><I><SUB>i</SUB></I> in DRA regulation are unknown. Wild type DRA and a mutant lacking the PDZ interaction motif (DRA-ETKFminus) were expressed constitutively in human embryonic kidney (HEK) and inducibly in Caco-2/BBE cells. DRA-mediated Cl/HCO<SUB>3</SUB> exchange was measured as intracellular pH changes. Ca<sup>2+</sup><I><SUB>i</SUB></I> was assessed fluorometrically. DRA was induced 8&ndash;16-fold and was delivered to the apical surface of polarized Caco-2 cells. Putative anion transporter 1 and cystic fibrosis transmembrane regulator did not contribute to Cl/HCO<SUB>3</SUB> exchange in transfected Caco-2 cells. The calcium ionophore 4Br-A23187 inhibited DRA and DRA-ETKFminus in HEK cells, but only full-length DRA was inhibited in Caco-2 cells. In contrast, 100 &micro;<scp>m</scp> UTP, which increased Ca<sup>2+</sup><I><SUB>i</SUB></I>, inhibited full-length DRA but not DRA-ETKFminus in Caco-2 and HEK cells. In HEK cells, which express little PDZK1, additional transfection of PDZK1 was required for UTP to inhibit DRA. As HEK cells do not express cystic fibrosis transmembrane regulator or NHE3, the data indicate that Ca<sup>2+</sup><I><SUB>i</SUB></I>-dependent DRA inhibition is not because of modulation of other transport activities. In polarized epithelium, this inhibition requires interaction of DRA with PDZK1. Together with data from PDZK1<sup>&ndash;/&ndash;</sup> mice, these data underscore the prominent role of PDZK1 in Ca<sup>2+</sup><I><SUB>i</SUB></I>-mediated inhibition of colonic NaCl absorption.</p>
]]></description>
<dc:creator><![CDATA[Lamprecht, G., Hsieh, C.-J., Lissner, S., Nold, L., Heil, A., Gaco, V., Schafer, J., Turner, J. R., Gregor, M.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.004127</dc:identifier>
<dc:title><![CDATA[Intestinal Anion Exchanger Down-regulated in Adenoma (DRA) Is Inhibited by Intracellular Calcium [Membrane Transport, Structure, Function, and Biogenesis]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19753</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19744</prism:startingPage>
<prism:section>Membrane Transport, Structure, Function, and Biogenesis</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/19754?rss=1">
<title><![CDATA[Chemical Genetic Profiling and Characterization of Small-molecule Compounds That Affect the Biosynthesis of Unsaturated Fatty Acids in Candida albicans [Lipids and Lipoproteins: Metabolism, Regulation, and Signaling]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/19754?rss=1</link>
<description><![CDATA[
<p>The balance between saturated and unsaturated fatty acids plays a crucial role in determining the membrane fluidity. In the diploid fungal pathogen <I>Candida albicans</I>, the gene for fatty acid 9 desaturase, <I>OLE1</I>, is essential for viability. Using a reverse genetic approach, termed the fitness test, we identified a group of structurally related synthetic compounds that induce specific hypersensitivity of the <I>OLE1</I><sup>+/&ndash;</sup> strain. Genetic repression of <I>OLE1</I> and chemical inhibition by two selected compounds, ECC145 and ECC188, resulted in a marked decrease in the total unsaturated fatty acids and impaired hyphal development. The resulting auxotroph of both was suppressed by the exogenous monounsaturated fatty acids (16:19 and 18:19). These correlations suggest that both compounds affect the level of unsaturated fatty acids, likely by impairing Ole1p directly or indirectly. However, the residual levels of monounsaturated fatty acids (MUFAs) resulted from chemical inhibition were significantly higher than <I>OLE1</I> repression, indicating even partial inhibition of MUFAs is sufficient to stop cellular proliferation. Although the essentiality of <I>OLE1</I> was suppressed by MUFAs <I>in vitro</I>, we demonstrated that it was required for virulence in a murine model of systemic candidiasis even when the animals were supplemented with a high fat diet. Thus, the fungal fatty acid desaturase is an attractive antifungal drug target. Taking advantage of the inhibitors and the relevant conditional shut-off strains, we validated several chemical genetic interactions observed in the fitness test profiles that reveal novel genetic interactions between <I>OLE1</I>/unsaturated fatty acids and other cellular processes.</p>
]]></description>
<dc:creator><![CDATA[Xu, D., Sillaots, S., Davison, J., Hu, W., Jiang, B., Kauffman, S., Martel, N., Ocampo, P., Oh, C., Trosok, S., Veillette, K., Wang, H., Yang, M., Zhang, L., Becker, J., Martin, C. E., Roemer, T.]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:identifier>info:doi/10.1074/jbc.M109.019877</dc:identifier>
<dc:title><![CDATA[Chemical Genetic Profiling and Characterization of Small-molecule Compounds That Affect the Biosynthesis of Unsaturated Fatty Acids in Candida albicans [Lipids and Lipoproteins: Metabolism, Regulation, and Signaling]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>19764</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>19754</prism:startingPage>
<prism:section>Lipids and Lipoproteins: Metabolism, Regulation, and Signaling</prism:section>
</item>

<item rdf:about="http://www.jbc.org/cgi/content/short/284/29/e99932?rss=1">
<title><![CDATA[pol II: Now Twice as Faithful{diamondsuit}: Rpb9 Subunit Controls Transcription Fidelity by Delaying NTP Sequestration in RNA Polymerase II [Papers Of The Week]]]></title>
<link>http://www.jbc.org/cgi/content/short/284/29/e99932?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2009-07-10</dc:date>
<dc:title><![CDATA[pol II: Now Twice as Faithful{diamondsuit}: Rpb9 Subunit Controls Transcription Fidelity by Delaying NTP Sequestration in RNA Polymerase II [Papers Of The Week]]]></dc:title>
<dc:publisher>ASBMB</dc:publisher>
<prism:number>29</prism:number>
<prism:volume>284</prism:volume>
<prism:endingPage>e99932</prism:endingPage>
<prism:publicationDate>2009-07-17</prism:publicationDate>
<prism:startingPage>e99932</prism:startingPage>
<prism:section>Papers Of The Week</prism:section>
</item>

</rdf:RDF>